🏷

Classifications

Harrison's Part

ICIMD (Inherited Metabolic Disorders)

👪

Inheritance

1

Autosomal Recessive HP:0000007

Biallelic (homozygous or compound heterozygous) pathogenic B3GAT3 variants are required. Most reported families are consanguineous and homozygous for a founder or private missense allele; compound heterozygosity, including a null allele in trans with a hypomorphic missense, has also been documented. Heterozygous carrier parents are unaffected.

Autosomal recessive inheritance

Show evidence (2 references)

PMID:34537402 SUPPORT Human Clinical

"Biallelic pathogenic variants in B3GAT3 hence lead to Linkeropathy due to loss of function or decreased activity of this enzyme."

States explicitly that biallelic variants are required.

PMID:34537402 SUPPORT Human Clinical

"Both unaffected parents (double second cousins) were shown to be heterozygous carriers."

Documents unaffected heterozygous carrier parents, the defining pattern of autosomal recessive inheritance.

◈

Mechanistic Hypotheses

1

Catalytic-subdomain location determines phenotype severity

subdomain_severity_gradient EMERGING

Evidence balance 1 support

Across the small published cohort, variants in the acceptor-substrate-binding subdomain of the GlcAT-I catalytic domain (p.Gly223Ser, p.Leu224Gln, p.Arg277Gln, p.Arg297Trp) segregate with the severe end of the spectrum — multiple fractures, craniosynostosis, cardiovascular malformation, and in the p.Gly223Ser cases death before one year — whereas donor-subdomain variants (p.Pro140Leu, p.Thr139Met, p.Arg161Trp) produce milder, sometimes purely skeletal disease. A compound heterozygote carrying one variant in each subdomain had an intermediate phenotype. The correlation rests on very few patients and is not yet supported by a systematic activity-versus-severity assay series, so it should be treated as emerging rather than as an established genotype-phenotype rule.

Show evidence (1 reference)

PMID:31438591 SUPPORT Human Clinical

"The heterogeneous LK phenotypes, ranging from mild to severe and even lethal presentations, seem to be related to specific B3GAT3 mutations, though there has been a limited number of patients and pathogenic variants described so far"

States both the genotype-phenotype correlation and the small-sample caveat that keeps this hypothesis at EMERGING status.

?

Discussions and Knowledge Gaps

3

Does the tissue-specific expression level of B3GAT3 relative to the other linker enzymes explain why cardiac malformation is characteristic of B3GAT3-related disease but not of B4GALT7/B3GALT6 spondylodysplastic EDS?

KNOWLEDGE GAP b3gat3_cardiac_tissue_specificity

Attached to

pathophysiology#Impaired Cardiac Valve and Great Vessel Development

The leading explanation for the cardiac specificity is that B3GAT3 is expressed more highly in heart than B3GALT6 and B4GALT7, so heart tissue is disproportionately sensitive to loss of this particular linker step. An alternative model holds that the linker enzymes act within a shared complex (a "GAGosome"), which would predict comparable rather than differential tissue sensitivity. Neither model has been tested directly in cardiac tissue, and the observation that the donor-subdomain p.Pro140Leu family had no cardiac phenotype at all suggests residual activity thresholds may matter as much as expression level.

Proposed experiments

Comparative linker-enzyme expression and activity mapping

linker_enzyme_expression_map

Quantify B3GAT3, B4GALT7 and B3GALT6 expression and GlcAT-I / GalT-I / GalT-II activity across human developing cardiac valve, aortic media, cartilage and bone to test whether cardiac tissue is disproportionately B3GAT3-dependent.

Tissue-resolved GAG quantification in linker-enzyme-deficient models

tissue_resolved_gag_quantification

Measure heparan and chondroitin/dermatan sulfate content in cardiac valve tissue from B3GAT3-deficient versus B4GALT7-deficient models to test differential tissue sensitivity.

Allelic-series threshold test in a vertebrate model

glcat1_allelic_series_threshold

Establish an allelic series (null, p.Gly223Ser, p.Pro140Leu) in a vertebrate model and test whether cardiac cushion phenotypes track residual GlcAT-I activity thresholds rather than pathway identity.

Should B3GAT3-related disease remain a separate nosologic entity, or be merged into a single gene-prefixed "linkeropathy" spectrum alongside XYLT1/XYLT2, B4GALT7 and B3GALT6 disorders?

KNOWLEDGE GAP linkeropathy_nosology_boundary

Attached to

pathophysiology#Incomplete GAG-Protein Tetrasaccharide Linker Assembly

All five linker enzymes act sequentially on the same tetrasaccharide and produce overlapping phenotypes, yet the 2017 EDS nosology admits only B4GALT7 and B3GALT6 (as spEDS) and leaves B3GAT3, XYLT1 and XYLT2 outside. The comprehensive 2019 review argues these are a phenotypic continuum and proposes gene-prefixed "linkeropathy" naming. dismech currently follows MONDO and keeps this entry separate from Spondylodysplastic Ehlers-Danlos Syndrome; a linkeropathy Grouping would be the natural way to represent the union without collapsing the entities.

Proposed experiments

Cross-gene linkeropathy deep phenotyping cohort

cross_gene_linkeropathy_phenotyping

Systematically phenotype a multi-gene linkeropathy cohort with a common instrument to test whether gene identity or residual enzyme activity better predicts the clinical profile.

Curate a dismech linkeropathy Grouping

linkeropathy_grouping_curation

Build a dismech Grouping over the linkeropathy entries with explicit membership criteria so the boundary between spEDS and the non-spEDS linkeropathies is auditable.

Does the zebrafish b3gat3 mutant's near-complete loss of chondroitin sulfate with retained heparan sulfate reflect human GlcAT-I deficiency, where patient fibroblasts show a more balanced reduction of dermatan, chondroitin and heparan sulfate proteoglycans?

HUMAN MODEL MISMATCH b3gat3_zebrafish_cs_hs_asymmetry

Attached to

pathophysiology#Combined Heparan and Chondroitin/Dermatan Sulfate Proteoglycan Deficiency

Both systems block the same shared linker step, so a priori both GAG arms should fall together — and that is what human fibroblast measurements show. The zebrafish model instead shows CS virtually abolished with ~50% of HS retained, implying a species- or context-dependent prioritization of HS over CS when linker flux is limiting. This matters mechanistically: if the human disease also preferentially spares HS, then the skeletal/cartilage phenotype (CS-dependent pericellular matrix) should dominate over HS-dependent morphogen-signalling phenotypes, which is broadly what is observed clinically. The mismatch is unresolved because the human data are semi-quantitative and come from fibroblasts rather than cartilage or cardiac tissue.

Proposed experiments

Quantitative CS/HS ratio in human B3GAT3 patient tissue

human_cs_hs_ratio_disease_tissue

Measure absolute chondroitin/dermatan sulfate and heparan sulfate chain abundance in patient-derived chondrocytes and iPSC-derived cardiac cells, not only dermal fibroblasts, to test whether the zebrafish CS-over-HS asymmetry holds in human disease-relevant cell types.

Humanized allele rescue in the zebrafish model

humanized_allele_zebrafish_rescue

Test whether human B3GAT3 disease alleles rescue the zebrafish b3gat3 cartilage phenotype in an allele-strength-dependent manner, and whether rescue restores chondroitin and heparan sulfate proportionately.

⚙

Pathophysiology

7

GlcAT-I Loss of Function

Biallelic B3GAT3 missense, start-loss, or in-frame deletion variants reduce or abolish the galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity of GlcAT-I. Disease-associated substitutions cluster in the two functional halves of the catalytic domain: the donor (UDP-GlcA) substrate-binding subdomain (p.Pro140Leu, p.Thr139Met, p.Arg161Trp) and the acceptor substrate-binding subdomain (p.Arg277Gln, p.Gly223Ser, p.Leu224Gln, p.Arg297Trp). Reduced activity is demonstrable both in patient-derived cells and for recombinant mutant protein.

B3GAT3 hgnc:923

glucuronosyltransferase-I (GlcAT-I) activity GO:0015018 ↓ DECREASED

Golgi apparatus GO:0005794

Downstream

Incomplete GAG-Protein Tetrasaccharide Linker Assembly Loss of the terminal glucuronosyl transfer step leaves the linker trisaccharide unfinished, so glycosaminoglycan polymerization cannot begin.

Show evidence (3 references)

PMID:21763480 SUPPORT In Vitro

"Patients' cells as well as recombinant mutant protein showed reduced glucuronyltransferase activity."

Directly demonstrates reduced GlcAT-I catalytic activity as the proximal molecular defect.

PMID:21763480 SUPPORT In Vitro

"Further studies demonstrated that GlcAT-I resides in the cis and cis-medial Golgi apparatus and is expressed in the affected tissues, i.e., heart, aorta, and bone."

Localizes the enzyme to the cis/cis-medial Golgi and shows expression in the tissues that are clinically affected.

PMID:31438591 SUPPORT Human Clinical

"the more severe phenotypes appear to harbor mutations located within the acceptor substrate binding subdomain of the catalytic domain of the protein, whereas more mildly affected patients seem to have mutations in the donor substrate binding subdomain"

Supports the subdomain-based genotype-phenotype correlation described for this node.

Incomplete GAG-Protein Tetrasaccharide Linker Assembly

All glycosaminoglycan chains — heparan sulfate and chondroitin/dermatan sulfate alike — are built on a single shared GlcA-Gal-Gal-Xyl tetrasaccharide linker attached to a serine of the proteoglycan core protein. GlcAT-I catalyzes the final, committing step of linker assembly, so its deficiency is a bottleneck upstream of every downstream GAG polymerase and sulfotransferase. This shared-bottleneck position is what defines the "linkeropathy" disease class and explains why one enzyme defect produces a pleiotropic connective tissue phenotype.

proteoglycan biosynthesis GO:0030166 ↓ DECREASED

Downstream

Combined Heparan and Chondroitin/Dermatan Sulfate Proteoglycan Deficiency Because the blocked step is shared, both the heparan sulfate and the chondroitin/dermatan sulfate arms of proteoglycan synthesis are reduced together rather than one selectively.

Show evidence (2 references)

PMID:26086840 SUPPORT Human Clinical

"Linkeropathies are due to enzymatic defects in the synthesis of the common linker region that joins the core proteins to their glycosaminoglycan (GAG) side chains."

Defines the shared-linker bottleneck that this node represents.

PMID:31438591 SUPPORT Human Clinical

"The linker region is completed by the transfer of glucuronic acid (GlcA) catalyzed by glucuronosyltransferase I (GlcAT-I encoded by B3GAT3), upon which polymerization of the HS or CS/DS chains begins."

States that GlcAT-I completes the linker and that HS and CS/DS polymerization is downstream of it.

Combined Heparan and Chondroitin/Dermatan Sulfate Proteoglycan Deficiency

Patient fibroblasts and lymphoblastoid cells carry reduced numbers of GAG side chains and reduced levels of heparan sulfate, chondroitin sulfate, and dermatan sulfate proteoglycans. Proteoglycans are not only structural space-filling ECM components but also co-receptors and morphogen reservoirs (FGF, BMP, Wnt, Hedgehog), so their simultaneous depletion degrades both the mechanical and the signalling functions of the matrix. The b3gat3 zebrafish mutant qualifies this picture: there, CS synthesis is virtually abolished while roughly half of normal HS output is retained, implying the two arms may not be equally sensitive to loss of the shared linker step.

dermal fibroblast CL:0002620

heparan sulfate proteoglycan biosynthesis GO:0015012 ↓ DECREASED chondroitin sulfate proteoglycan biosynthesis GO:0050650 ↓ DECREASED

Downstream

Proteoglycan-Deficient Extracellular Matrix Loss of GAG-bearing proteoglycans changes the composition and mechanical behaviour of the extracellular matrix in connective tissue.

Show evidence (3 references)

PMID:21763480 SUPPORT In Vitro

"Patient fibroblasts demonstrated decreased levels of dermatan sulfate, chondroitin sulfate, and heparan sulfate proteoglycans, indicating that the defect in linker synthesis affected all three lines of O-glycanated proteoglycans."

Direct patient-cell measurement of the combined DS/CS/HS proteoglycan deficiency.

PMID:25893793 SUPPORT In Vitro

"Moreover, relative numbers of glycosaminoglycan (GAG) side chains were decreased in patient cells."

Independent confirmation of reduced GAG side-chain occupancy in patient cells.

PMID:22869369 SUPPORT Model Organism

"In uxs1 and b3gat3 mutant larvae, biosynthesis of CS was shown to be virtually abolished, whereas these mutants still were capable of synthesizing 50% of the HS produced in control larvae."

Zebrafish b3gat3 mutants show a markedly asymmetric CS-versus-HS deficit, qualifying (rather than simply confirming) the balanced reduction inferred from human fibroblasts.

Proteoglycan-Deficient Extracellular Matrix

The proteoglycan-poor matrix is mechanically weaker and signals abnormally in the tissues where B3GAT3 is most highly expressed — cartilage, bone, tendon, skeletal muscle, heart and aorta. This is the convergence point from which the three principal clinical arms of the disease diverge: skeletal, articular, and cardiovascular.

fibroblast CL:0000057 chondrocyte CL:0000138

extracellular matrix organization GO:0030198 ⚠ ABNORMAL

musculoskeletal system UBERON:0002204

Downstream

Impaired Skeletal Growth and Bone Mineralization Cartilage and bone matrix depend heavily on proteoglycan content, so the matrix defect manifests as disproportionate short stature, metaphyseal and epiphyseal dysplasia, radioulnar synostosis and low bone mineral density.

Joint Capsule and Ligament Laxity Weakened, proteoglycan-poor periarticular connective tissue permits congenital and recurrent large-joint dislocation and, paradoxically, joint contracture.

Impaired Cardiac Valve and Great Vessel Development Cardiac cushion and valve morphogenesis and aortic wall assembly are proteoglycan-dependent; B3GAT3 is expressed in heart and aorta and is relatively more highly expressed in heart than the other linker enzymes, which is the leading explanation for why cardiac malformation is the distinguishing feature of this linkeropathy.

Show evidence (1 reference)

PMID:21763480 SUPPORT Human Clinical

"Proteoglycans are a major component of extracellular matrix and contribute to normal embryonic and postnatal development by ensuring tissue stability and signaling functions."

Establishes the dual structural and signalling role of the proteoglycan-bearing matrix that is lost here.

Impaired Skeletal Growth and Bone Mineralization

Chondrocyte and osteoblast function in a proteoglycan-poor matrix yields disproportionate short stature, metaphyseal flaring and epiphyseal dysplasia, radioulnar synostosis, kyphoscoliosis, and reduced bone mineral density that in severely affected individuals progresses to generalized osteoporosis with multiple fractures. In the most severe (acceptor-subdomain) genotypes the cranial sutures fuse prematurely, producing craniosynostosis and an Antley-Bixler-like prenatal presentation.

chondrocyte CL:0000138 osteoblast CL:0000062

bone mineralization GO:0030282 ↓ DECREASED cartilage development GO:0051216 ⚠ ABNORMAL

bone element UBERON:0001474

Show evidence (2 references)

PMID:28771243 SUPPORT Human Clinical

"We identified a novel B3GAT3-related disorder with craniosynostosis and bone fragility, due to a unique homozygous mutation in B3GAT3."

Establishes craniosynostosis and bone fragility as part of the severe end of the skeletal arm.

PMID:27871226 SUPPORT Human Clinical

"a 4-year-old patient with a severe phenotype of osteoporosis, hypotonia, joint laxity, fractures, scoliosis, biscuspid aortic valve and myopia"

Documents osteoporosis, fractures and scoliosis in a functionally validated B3GAT3 patient.

Joint Capsule and Ligament Laxity

Ligaments, joint capsules and tendons depend on proteoglycan-rich matrix for tensile integrity. Their weakening produces the cardinal congenital large-joint dislocations (hips, elbows, knees) and generalized joint hypermobility, while the same abnormal periarticular tissue also gives rise to fixed joint contractures — an unusual coexistence of laxity and contracture that is characteristic of B3GAT3 (and B3GALT6) disease among the linkeropathies.

skeletal joint UBERON:0000982

Show evidence (2 references)

PMID:21763480 SUPPORT Human Clinical

"We studied five patients with recessive joint dislocations and congenital heart defects, including bicuspid aortic valve (BAV) and aortic root dilatation."

The founding cohort was ascertained on recessive joint dislocations, anchoring this node clinically.

PMID:31438591 SUPPORT Human Clinical

"While joint hypermobility is a common trait of all LKs, joint contractures are more frequently observed in patients with B3GAT3 and B3GALT6 mutations."

Supports the coexistence of hypermobility with contractures and its relative specificity for B3GAT3.

Impaired Cardiac Valve and Great Vessel Development

Proteoglycan-rich cardiac jelly and valve interstitial matrix are required for endocardial cushion remodelling and semilunar/atrioventricular valve morphogenesis, and proteoglycans are structural constituents of the aortic media. GlcAT-I deficiency therefore yields bicuspid aortic valve, mitral valve prolapse, atrial and ventricular septal defects, and progressive aortic root dilatation. Cardiovascular involvement is the feature that most sharply distinguishes B3GAT3-related disease from the B4GALT7/B3GALT6 spondylodysplastic Ehlers-Danlos linkeropathies, and it is genotype-dependent: the Nias p.Pro140Leu donor-subdomain family had no detectable cardiac phenotype.

heart valve development GO:0003170 ⚠ ABNORMAL

cardiac valve UBERON:0000946 aorta UBERON:0000947

Show evidence (3 references)

PMID:21763480 SUPPORT Human Clinical

"The described family constitutes a syndrome characterized by heart defects and joint dislocations resulting from altered initiation of proteoglycan synthesis (Larsen-like syndrome, B3GAT3 type)."

Attributes the cardiac defects directly to altered initiation of proteoglycan synthesis, and names the disease entity.

PMID:25893793 SUPPORT Human Clinical

"no heart phenotype could be detected in our family."

Qualifies the cardiac arm as genotype-dependent rather than obligate — the donor-subdomain p.Pro140Leu Nias family had no heart involvement, in explicit contrast to the p.Arg277Gln families.

PMID:31438591 SUPPORT Human Clinical

"Concerning cardiovascular involvement, anomalies such as septal defects, aortic valve dysplasia, aortic root and ascending aorta dilatation, and mitral valve prolapse, are more recurrent in B3GAT3-related disorders as well as in SOS."

Establishes cardiovascular involvement as comparatively characteristic of B3GAT3-related disease among the linkeropathies.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

26

Cardiovascular 4

Bicuspid Aortic Valve HP:0001647

Show evidence (2 references)

PMID:21763480 SUPPORT Human Clinical

"We studied five patients with recessive joint dislocations and congenital heart defects, including bicuspid aortic valve (BAV) and aortic root dilatation."

Bicuspid aortic valve documented in the founding cohort.

PMID:27871226 SUPPORT Human Clinical

"a 4-year-old patient with a severe phenotype of osteoporosis, hypotonia, joint laxity, fractures, scoliosis, biscuspid aortic valve and myopia"

Independent case with bicuspid aortic valve.

Aortic Root Dilatation Aortic root aneurysm HP:0002616

Course: PROGRESSIVE

Show evidence (2 references)

PMID:35151321 SUPPORT Human Clinical

"Our patient was the youngest, at the age of 2 months, to experience aortic root dilation."

Documents the earliest reported onset of aortic root dilatation in this disorder.

PMID:39359951 SUPPORT Human Clinical

"The 14-year-old boy exhibited short stature, severe kyphoscoliosis, splenomegaly, and aortic root dilatation"

Independent case with aortic root dilatation in adolescence.

Septal Defects Ventricular septal defect HP:0001629

Show evidence (2 references)

PMID:21763480 SUPPORT Human Clinical

"results in variable combinations of heart malformations, including mitral valve prolapse, ventricular septal defect, and bicuspid aortic valve."

Ventricular septal defect named among the recurrent malformations.

PMID:26086840 SUPPORT Human Clinical

"bilateral club feet, and atrial and ventricular septal defects."

Documents both atrial and ventricular septal defects.

Mitral Valve Prolapse HP:0001634

Show evidence (1 reference)

PMID:21763480 SUPPORT Human Clinical

"results in variable combinations of heart malformations, including mitral valve prolapse, ventricular septal defect, and bicuspid aortic valve."

Mitral valve prolapse named among the recurrent cardiac malformations.

Ear 1

Sensorineural Hearing Loss OCCASIONAL Sensorineural hearing impairment HP:0000407

Show evidence (1 reference)

PMID:26086840 SUPPORT Human Clinical

"arachnodactyly, overlapping fingers with ulnar deviation, lymphedema, hypotonia, hearing loss, and perinatal cerebral infarction"

Hearing loss reported as a novel finding in a single severe case, supporting the OCCASIONAL band.

Eye 3

Hypertelorism HP:0000316

Show evidence (1 reference)

PMID:26086840 SUPPORT Human Clinical

"He had the additional features of bilateral glaucoma, hypertelorism, upturned nose with anteverted nares, a small chest, a diaphragmatic hernia, multiple fractures, arachnodactyly, overlapping fingers with ulnar deviation, lymphedema, hypotonia, hearing loss, and perinatal cerebral infarction"

Documents hypertelorism and the upturned nose with anteverted nares.

Blue Sclerae HP:0000592

Show evidence (2 references)

PMID:26086840 SUPPORT Human Clinical

"We report on a patient with a novel homozygous B3GAT3 (c.667G>A, p.Gly223Ser) mutation and a history of multiple fractures, blue sclerae, and glaucoma."

Documents blue sclerae.

PMID:39359951 SUPPORT Human Clinical

"along with several physical abnormalities including bifid uvula, blue sclera, limited elbow extension, and pectus carinatum."

Independent case with blue sclerae.

Glaucoma OCCASIONAL HP:0000501

Show evidence (1 reference)

PMID:26086840 SUPPORT Human Clinical

"He had the additional features of bilateral glaucoma, hypertelorism, upturned nose with anteverted nares, a small chest, a diaphragmatic hernia, multiple fractures, arachnodactyly, overlapping fingers with ulnar deviation, lymphedema, hypotonia, hearing loss, and perinatal cerebral infarction"

Bilateral glaucoma reported in a single severe case, supporting the OCCASIONAL band rather than a core feature.

Head and Neck 3

Craniosynostosis OCCASIONAL HP:0001363

Show evidence (1 reference)

PMID:28771243 SUPPORT Human Clinical

"Based on prenatal suspicion of the combination of radioulnar or radiohumeral synostosis and a peculiar shape of the skull suggestive of craniosynostosis, we report on six patients from four unrelated consanguineous families in whom Antley-Bixler syndrome was suspected during the prenatal period"

Six patients from four families with craniosynostosis; restricted to one severe genotype, hence OCCASIONAL rather than a general feature.

Midface Hypoplasia Midface retrusion HP:0011800

Show evidence (2 references)

PMID:28771243 SUPPORT Human Clinical

"These patients featured mainly craniosynostosis, midface hypoplasia, bilateral radioulnar synostosis, multiple neonatal fractures, dislocated joints, joint contracture, long fingers, foot deformity, and cardiovascular abnormalities."

Midface hypoplasia in all six patients of the severe series.

PMID:31438591 SUPPORT Human Clinical

"Among the plethora of craniofacial dysmorphism, midface hypoplasia, craniosynostosis, and short/webbed neck are particularly frequent in B3GAT3-related disorders."

Identifies midface hypoplasia as particularly frequent in B3GAT3 disease.

Short Neck HP:0000470

Show evidence (1 reference)

PMID:31438591 SUPPORT Human Clinical

"Among the plethora of craniofacial dysmorphism, midface hypoplasia, craniosynostosis, and short/webbed neck are particularly frequent in B3GAT3-related disorders."

Short/webbed neck identified as particularly frequent in B3GAT3 disease.

Limbs 3

Radioulnar Synostosis FREQUENT HP:0002974

Show evidence (2 references)

PMID:28771243 SUPPORT Human Clinical

"These patients featured mainly craniosynostosis, midface hypoplasia, bilateral radioulnar synostosis, multiple neonatal fractures, dislocated joints, joint contracture, long fingers, foot deformity, and cardiovascular abnormalities."

Bilateral radioulnar synostosis in all six patients of this series.

PMID:31438591 SUPPORT Human Clinical

"Radioulnar synostosis seems more specific for B3GAT3-and B4GALT7-related disorders"

Identifies radioulnar synostosis as comparatively specific for B3GAT3 disease.

Foot Deformity Talipes equinovarus HP:0001762

Show evidence (1 reference)

PMID:26086840 SUPPORT Human Clinical

"like previously reported patients, he had bilateral radio-ulnar synostosis, severe osteopenia, an increased gap between first and second toes, bilateral club feet, and atrial and ventricular septal defects."

Documents bilateral club feet and the increased first-second toe gap.

Arachnodactyly HP:0001166

Show evidence (1 reference)

PMID:26086840 SUPPORT Human Clinical

"He had the additional features of bilateral glaucoma, hypertelorism, upturned nose with anteverted nares, a small chest, a diaphragmatic hernia, multiple fractures, arachnodactyly, overlapping fingers with ulnar deviation, lymphedema, hypotonia, hearing loss, and perinatal cerebral infarction"

Documents arachnodactyly and overlapping fingers.

Musculoskeletal 7

Multiple Congenital Joint Dislocations VERY_FREQUENT HP:0001373

Temporal: RECURRENT

Show evidence (2 references)

PMID:21763480 SUPPORT Human Clinical

"We studied five patients with recessive joint dislocations and congenital heart defects, including bicuspid aortic valve (BAV) and aortic root dilatation."

All five patients in the founding cohort had joint dislocations.

PMID:31438591 SUPPORT Human Clinical

"The phenotypic features with a high rate of incidence shared among all LKs include short stature, joint laxity with dislocations, craniofacial dysmorphism (especially prominent forehead/eyes and blue sclerae), pectus abnormalities, peculiar fingers, foot deformities, and to a variable degree..."

Supports the VERY_FREQUENT band — dislocations are among the features with a high rate of incidence across the linkeropathies including B3GAT3.

Joint Hypermobility HP:0001382

Show evidence (1 reference)

PMID:31438591 SUPPORT Human Clinical

"While joint hypermobility is a common trait of all LKs, joint contractures are more frequently observed in patients with B3GAT3 and B3GALT6 mutations."

Documents joint hypermobility as a common feature of the linkeropathies including B3GAT3.

Joint Contractures HP:0034392

Show evidence (1 reference)

PMID:28771243 SUPPORT Human Clinical

"These patients featured mainly craniosynostosis, midface hypoplasia, bilateral radioulnar synostosis, multiple neonatal fractures, dislocated joints, joint contracture, long fingers, foot deformity, and cardiovascular abnormalities."

Lists joint contracture among the core features in six B3GAT3 patients.

Reduced Bone Mineral Density FREQUENT Osteopenia HP:0000938

Course: PROGRESSIVE

Show evidence (2 references)

PMID:26086840 SUPPORT Human Clinical

"like previously reported patients, he had bilateral radio-ulnar synostosis, severe osteopenia, an increased gap between first and second toes, bilateral club feet, and atrial and ventricular septal defects."

Severe osteopenia described as a feature shared with previously reported patients.

PMID:31438591 SUPPORT Human Clinical

"Low bone mineral density/osteopenia and radiographic abnormalities are also very common"

Supports the FREQUENT band for low bone mineral density across linkeropathies.

Kyphoscoliosis HP:0002751

Course: PROGRESSIVE

Show evidence (2 references)

PMID:39359951 SUPPORT Human Clinical

"The 14-year-old boy exhibited short stature, severe kyphoscoliosis, splenomegaly, and aortic root dilatation, along with several physical abnormalities including bifid uvula, blue sclera, limited elbow extension, and pectus carinatum."

Documents severe kyphoscoliosis in a homozygous c.416C>T patient.

PMID:34537402 SUPPORT Human Clinical

"The disease history includes congenital severe joint malalignment of elbows, hips, knees and feet, hypermobility, severe kyphoscoliosis, osteoporosis with multiple fractures in childhood, congenital diaphragmatic hernia, minor dental anomalies, digital malformations, and characteristic facial features."

Severe kyphoscoliosis persisting into adult life in a p.Leu21del homozygote.

Pectus Carinatum HP:0000768

Show evidence (1 reference)

PMID:39359951 SUPPORT Human Clinical

"along with several physical abnormalities including bifid uvula, blue sclera, limited elbow extension, and pectus carinatum."

Documents pectus carinatum in a B3GAT3 patient.

Hypotonia VERY_FREQUENT HP:0001252

Show evidence (2 references)

PMID:27871226 SUPPORT Human Clinical

"a 4-year-old patient with a severe phenotype of osteoporosis, hypotonia, joint laxity, fractures, scoliosis, biscuspid aortic valve and myopia"

Documents hypotonia in a functionally validated B3GAT3 patient.

PMID:24668659 SUPPORT Human Clinical

"Hypotonia seems ubiquitous, whereas developmental delay is only present in some patients."

Describes hypotonia as ubiquitous across linkeropathy patients, supporting the VERY_FREQUENT band.

Nervous System 1

Developmental Delay OCCASIONAL Global developmental delay HP:0001263

Show evidence (2 references)

PMID:24668659 SUPPORT Human Clinical

"However, he also has developmental delay, a refractive errors, dental defects, pectus carinatum, and skin abnormalities that have only been associated with linkeropathies caused by mutations in B4GALT6 and B4GALT7."

Documents developmental delay as a phenotype-expanding finding.

PMID:24668659 SUPPORT Human Clinical

"Hypotonia seems ubiquitous, whereas developmental delay is only present in some patients."

Explicitly contrasts ubiquitous hypotonia with developmental delay present only in some patients, supporting the OCCASIONAL band.

Growth 1

Short Stature VERY_FREQUENT HP:0004322

Show evidence (2 references)

PMID:26086840 SUPPORT Human Clinical

"Linkeropathies are a group of syndromes characterized by short stature, radio-ulnar synostosis, decreased bone density, congenital contractures and dislocations, joint laxity, broad digits, brachycephaly, small mouth, prominent eyes, short or webbed neck, congenital heart defects and mild..."

Short stature is listed first among the defining linkeropathy features.

PMID:24668659 SUPPORT Human Clinical

"Short stature is ubiquitous, but possibly more pronounced in the B3GALT6 and B4GALT7 mutations."

Explicitly describes short stature as ubiquitous across linkeropathy patients, supporting the VERY_FREQUENT band.

Other 3

Bone Fragility with Multiple Fractures Increased susceptibility to fractures HP:0002659

Show evidence (2 references)

PMID:28771243 SUPPORT Human Clinical

"We identified a novel B3GAT3-related disorder with craniosynostosis and bone fragility, due to a unique homozygous mutation in B3GAT3."

Establishes bone fragility as a documented B3GAT3 phenotype.

PMID:26086840 SUPPORT Human Clinical

"We report on a patient with a novel homozygous B3GAT3 (c.667G>A, p.Gly223Ser) mutation and a history of multiple fractures, blue sclerae, and glaucoma."

Documents multiple fractures in a p.Gly223Ser homozygote.

Broad Fingertips HP:0011300

Show evidence (1 reference)

PMID:26086840 SUPPORT Human Clinical

"Linkeropathies are a group of syndromes characterized by short stature, radio-ulnar synostosis, decreased bone density, congenital contractures and dislocations, joint laxity, broad digits, brachycephaly, small mouth, prominent eyes, short or webbed neck, congenital heart defects and mild..."

Broad digits listed among the defining features.

Congenital Diaphragmatic Hernia OCCASIONAL HP:0000776

Show evidence (2 references)

PMID:34537402 SUPPORT Human Clinical

"hypermobility, severe kyphoscoliosis, osteoporosis with multiple fractures in childhood, congenital diaphragmatic hernia, minor dental anomalies, digital malformations, and characteristic facial features."

Documents congenital diaphragmatic hernia in an adult B3GAT3 patient.

PMID:26086840 SUPPORT Human Clinical

"a small chest, a diaphragmatic hernia, multiple fractures,"

Independent case with diaphragmatic hernia.

🧬

Genetic Associations

1

B3GAT3

Gene: B3GAT3 hgnc:923 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (3 references)

PMID:21763480 SUPPORT Human Clinical

"We identified linkage to chromosome 11 and detected a mutation (c.830G>A, p.Arg277Gln) in B3GAT3, the gene coding for glucuronosyltransferase-I (GlcAT-I)."

Original gene discovery establishing B3GAT3 as the cause of the Larsen-like joint dislocation plus congenital heart defect syndrome.

PMID:27871226 SUPPORT In Vitro

"Independent in vitro assessment of each variant confirmed the B3GAT3: c.1A > G (p.Met1?) variant is functionally null and the c.671 T > A (p.L224Q) missense variant has significantly reduced glucuronyltransferase activity (~3% of control)."

Functional confirmation that pathogenic B3GAT3 alleles act by loss of glucuronyltransferase activity, including a true null allele.

PMID:39359951 SUPPORT Human Clinical

"Clinical exome sequencing analysis revealed a homozygous c.416C>T variant in the B3GAT3 gene for the sister; the same variant was also present in the boy patient."

Documents a recurrent homozygous B3GAT3 allele in the Turkish population.

💊

Medical Actions

4

Orthopedic and Spinal Surgery

Action: orthopedic surgical procedure Ontology label: Orthopedic Surgical Procedure NCIT:C16186

Management is entirely supportive; no disease-modifying therapy exists. Severe progressive kyphoscoliosis has been managed with preoperative halo-gravity traction followed by posterior instrumentation and spinal fusion. Joint dislocations, foot deformity and cervical instability are addressed by conventional orthopedic means, with the caveat that surgical results are often unsatisfactory in this connective tissue context.

Target Phenotypes: Kyphoscoliosis HP:0002751

Show evidence (1 reference)

PMID:39359951 SUPPORT Human Clinical

"The boy underwent preoperative halo-gravity traction for severe kyphoscoliosis, followed by posterior instrumentation and fusion surgery without complications."

Documents the spinal surgical approach used and its uncomplicated outcome.

Bisphosphonate Therapy for Low Bone Mineral Density

Action: bisphosphonate pharmacotherapy Ontology label: Pharmacotherapy NCIT:C15986

Bisphosphonates have been used for the osteopenia/osteoporosis of B3GAT3 disease, but the reported outcomes are equivocal — one patient remained severely osteopenic with delayed bone age despite treatment. Evidence is anecdotal and no controlled data exist.

Target Phenotypes: Osteopenia HP:0000938

Show evidence (1 reference)

PMID:31438591 SUPPORT Human Clinical

"DEXA confirmed severe osteopenia and delayed bone age despite bisphosphonates treatment; no fractures were reported."

Documents bisphosphonate use but with persistent severe osteopenia, so support for benefit is only partial.

Cardiovascular Surveillance and Surgical Repair

Action: cardiac surgical procedure Ontology label: Surgical Procedure NCIT:C15329

Lifelong echocardiographic surveillance for valve disease and progressive aortic root/ascending aortic dilatation is warranted given the early onset reported (from two months of age), with surgical closure of haemodynamically significant septal defects. One reported patient required surgical ASD closure after developing tachyarrhythmia and pulmonary hypertension.

Target Phenotypes: Ventricular septal defect HP:0001629 Aortic root dilatation HP:0002616

Show evidence (1 reference)

PMID:31438591 SUPPORT Human Clinical

"At the age of two, a heart ultrasound revealed an atrial septal defect, which was surgically treated three years later due to tachyarrhythmia and pulmonary hypertension."

Documents surgical repair of a septal defect prompted by complications.

Genetic Counseling

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Autosomal recessive inheritance implies a 25% recurrence risk for siblings. Counseling is particularly relevant given the high proportion of consanguineous families, the availability of recurrent founder alleles for targeted testing (p.Arg277Gln in the United Arab Emirates, p.Thr139Met in Turkey, p.Pro140Leu on Nias), and the prenatal detectability of the severe craniosynostosis/synostosis phenotype on ultrasound.

Show evidence (1 reference)

PMID:34537402 SUPPORT Human Clinical

"Both unaffected parents (double second cousins) were shown to be heterozygous carriers."

Confirms carrier status of consanguineous parents, the basis for recurrence-risk counseling.

🔬

Diagnosis

2

Molecular Genetic Testing (Exome/Genome Sequencing)

Diagnosis rests on identification of biallelic pathogenic B3GAT3 variants. In practice most patients have been ascertained by trio exome or clinical exome sequencing after a clinical diagnosis of Larsen syndrome, spondylodysplastic Ehlers-Danlos syndrome, Marfan syndrome, Antley-Bixler syndrome or Shprintzen-Goldberg syndrome proved genetically unconfirmed — the phenotypic overlap is close enough that B3GAT3 is frequently missed on targeted panels.

Show evidence (2 references)

PMID:28771243 SUPPORT Human Clinical

"Molecular diagnosis involved whole-exome and gene-panel sequencing."

Documents the diagnostic modality used.

PMID:35151321 SUPPORT Human Clinical

"We diagnosed a patient with congenital heart defects at an early age with a B3GAT3-related disorder instead of Marfan syndrome"

Illustrates that molecular testing reclassifies clinically Marfan-suspected patients as B3GAT3-related disease.

Glucuronyltransferase Activity Assay

Enzymatic assay of GlcAT-I activity in patient fibroblasts or lymphoblastoid cells, and quantification of GAG side-chain occupancy, can support the pathogenicity of variants of uncertain significance. This is a research-level assay rather than a routine clinical test.

Show evidence (1 reference)

PMID:27871226 SUPPORT In Vitro

"demonstrating the patient had a decrease both in the protein level of B3GAT3 and in the glucuronyltransferase activity when compared to control samples."

Demonstrates the assay used to establish variant pathogenicity.

📈

Progression

2

Perinatal-lethal severe course

Age: Prenatal period to 1 year

Patients homozygous for the acceptor-subdomain p.Gly223Ser allele present prenatally with craniosynostosis and radioulnar/radiohumeral synostosis and have a uniformly fatal course in the first year of life, with multiple neonatal fractures, joint dislocations and contractures, and cardiovascular malformation.

Show evidence (1 reference)

PMID:28771243 SUPPORT Human Clinical

"All died before 1 year of age."

Documents uniform death before age one in the six p.Gly223Ser patients.

Survival to adulthood in milder genotypes

Age: Birth to adulthood

Milder genotypes are compatible with survival into adult life, though with substantial cumulative morbidity — fixed joint malalignment, severe kyphoscoliosis, osteoporosis with childhood fractures, and dental anomalies.

Show evidence (1 reference)

PMID:34537402 SUPPORT Human Clinical

"Previously described patients of B3GAT3-deficiency were, however, all children with phenotypes ranging from prenatal manifestation and early lethality to less severe."

Frames this report as the first adult phenotype, establishing that survival to adulthood is possible in milder disease.

📊

Prevalence

1

Worldwide

Cases In Literature Ultra Rare

Only 26 molecularly confirmed patients from 13 families had been reported in the literature as of the 2019 comprehensive review; a handful of further cases have since been published (e.g. a Chinese infant in 2022 and two Turkish siblings in 2024). No population prevalence estimate exists.

Show evidence (1 reference)

PMID:31438591 SUPPORT Human Clinical

"Table 2 summarizes the clinical features of the 26 patients from 13 different families, 11 of which were consanguineous with B3GAT3 mutations reported so far"

Provides the cumulative published case count, supporting an ultra-rare cases-in-literature occurrence measure rather than a population rate.

🔀

Differential Diagnoses

7

Conditions with similar clinical presentations that must be differentiated from Larsen-like Syndrome B3GAT3 Type:

Spondylodysplastic Ehlers-Danlos Syndrome MONDO:0007526

Overlapping Features The B4GALT7- and B3GALT6-related linkeropathies are the immediate mechanistic neighbours of B3GAT3 disease — they block the two galactosyl transfer steps of the same tetrasaccharide linker — and were incorporated into the 2017 EDS nosology as spEDS, together with SLC39A13-spEDS.

Distinguishing Features

B3GAT3 disease is deliberately not classified within spEDS in the 2017 EDS nosology despite the shared pathogenic mechanism.
Cardiovascular malformation and craniosynostosis are more characteristic of B3GAT3 disease.
Marked skin hyperextensibility, doughy or translucent skin and atrophic scarring are more characteristic of spEDS.
Platyspondyly, the hallmark of spondylodysplasia, is essentially absent in B3GAT3-related disease.

Show evidence (2 references)

PMID:31438591 SUPPORT Human Clinical

"Patients with B3GAT3, XYLT1, and XYLT2 mutations were also not classified as spEDS, even though there is a common pathogenic mechanism and numerous shared clinical features."

Confirms that B3GAT3 disease sits outside the spEDS nosologic bucket despite the shared mechanism — the key positioning statement for this entry.

PMID:31438591 SUPPORT Human Clinical

"Platyspondyly, a hallmark of “spondylo”-dysplasia, has never been recognized in B4GALT7-spEDS and B3GAT3-related disorders"

Provides the platyspondyly discriminator relative to B3GALT6-spEDS.

Antley-Bixler Syndrome Not Yet Curated MONDO:0008803

Overlapping Features The prenatal combination of craniosynostosis with radiohumeral or radioulnar synostosis is the classic Antley-Bixler presentation and is exactly what the severe p.Gly223Ser B3GAT3 genotype mimics.

Distinguishing Features

Antley-Bixler syndrome is caused by FGFR2 or POR variants; the severe B3GAT3 patients were negative for the known Antley-Bixler genes.
B3GAT3 patients additionally show multiple neonatal fractures, joint dislocations and cardiovascular abnormalities.

Show evidence (2 references)

PMID:28771243 SUPPORT Human Clinical

"This syndrome should be considered in the prenatal period in light of the severe outcome and as an alternative diagnosis to Antley-Bixler or Shprintzen-Goldberg syndrome."

Explicitly recommends B3GAT3 disease as a prenatal alternative diagnosis to Antley-Bixler and Shprintzen-Goldberg syndromes.

PMID:28771243 SUPPORT Human Clinical

"we report on six patients from four unrelated consanguineous families in whom Antley-Bixler syndrome was suspected during the prenatal period without mutation in genes known to be associated with the syndrome."

Documents that the B3GAT3 patients were negative for the known Antley-Bixler genes.

Shprintzen-Goldberg Syndrome MONDO:0008426

Overlapping Features Postnatally the association of craniosynostosis with arachnodactyly and a Marfanoid habitus suggests Shprintzen-Goldberg syndrome; at least one B3GAT3 patient carried that clinical label for years before molecular diagnosis.

Distinguishing Features

Shprintzen-Goldberg syndrome characteristically includes intellectual disability and brain anomalies, both absent in the B3GAT3 patient who had been misdiagnosed as SGS.

Show evidence (1 reference)

PMID:31438591 SUPPORT Human Clinical

"Interestingly, our patient received a diagnosis of SGS in infancy, though there was the absence of several cardinal features, above all intellectual disability and brain abnormalities."

Documents the SGS misdiagnosis and the absent cardinal SGS features that distinguish it.

Marfan Syndrome MONDO:0007947

Overlapping Features Arachnodactyly with aortic root dilatation in an infant readily suggests Marfan syndrome, and a B3GAT3 patient was so labelled at birth.

Distinguishing Features

Marfan syndrome is autosomal dominant and FBN1-related, with tall stature and ectopia lentis.
B3GAT3 patients have short stature, congenital joint dislocations, radioulnar synostosis and reduced bone mineral density.

Show evidence (1 reference)

PMID:35151321 SUPPORT Human Clinical

"We report for the first time two heterozygous variants of B3GAT3 in a Chinese infant, in whom Marfan syndrome was suspected at birth."

Documents the Marfan misdiagnosis that molecular testing corrected.

Geroderma Osteodysplastica Not Yet Curated MONDO:0009271

Overlapping Features A geroderma osteodysplastica-like presentation with cutis laxa, generalized osteoporosis with fractures and spondyloepimetaphyseal dysplasia has been reported with the homozygous B3GAT3 p.Pro82Leu allele.

Distinguishing Features

Geroderma osteodysplastica proper is caused by GORAB variants; the B3GAT3 phenocopy is distinguished molecularly rather than clinically.

Show evidence (1 reference)

PMID:31438591 SUPPORT Human Clinical

"reported a GO–like syndrome in a patient carrying the homozygous c.245C>T, p.(Pro82Leu) missense variant in the donor substrate binding subdomain of the protein."

Documents the geroderma osteodysplastica-like B3GAT3 presentation.

🐁

Animal Models

1

b3gat3 mutant Danio rerio (zebrafish) Skeletal

The b3gat3 zebrafish mutant is the only well-characterized animal model of GlcAT-I deficiency. It develops abnormal pharyngeal cartilage morphology with failure of pericellular extracellular matrix formation around chondrocytes, recapitulating the cartilage arm of the human disease. Biochemically the model is informative but not a straightforward mirror of the human data: chondroitin sulfate biosynthesis is virtually abolished while about half of normal heparan sulfate output persists, whereas human patient fibroblasts show a more balanced reduction across dermatan, chondroitin and heparan sulfate proteoglycans. The model has not been reported to reproduce the human cardiac valve and great-vessel malformations.

Species

Danio rerio (zebrafish)

Genotype

b3gat3 mutant

Genes

B3GAT3 hgnc:923

Show evidence (2 references)

PMID:22869369 SUPPORT Model Organism

"uxs1 and b3gat3 mutants, predicted to have impaired biosynthesis of both HS and CS because of defective formation of the common proteoglycan linkage tetrasaccharide were analyzed"

Identifies the zebrafish b3gat3 mutant as a linker-region-deficient model matching the human molecular lesion.

PMID:22869369 SUPPORT Model Organism

"impaired CS biosynthesis inhibited formation of the extracellular matrix surrounding chondrocytes."

Provides the cartilage-specific mechanistic readout — loss of pericellular extracellular matrix around chondrocytes.

{ }

Source YAML

click to show

name: Larsen-like Syndrome B3GAT3 Type
creation_date: '2026-08-01T00:00:00Z'
category: Mendelian
description: >
  Larsen-like syndrome, B3GAT3 type — also called multiple joint dislocations,
  short stature, craniofacial dysmorphism, with or without congenital heart
  defects (JDSCD), and increasingly in the literature "B3GAT3-related
  linkeropathy" — is an ultra-rare autosomal recessive multisystem connective
  tissue and skeletal disorder caused by biallelic loss-of-function variants in
  B3GAT3. B3GAT3 encodes glucuronosyltransferase-I (GlcAT-I), the Golgi enzyme
  that transfers the terminal glucuronic acid onto the Gal-Gal-Xyl trisaccharide
  to complete the tetrasaccharide linker region common to all
  glycosaminoglycan-bearing proteoglycans. Because this linker is shared, GlcAT-I
  deficiency simultaneously blocks initiation of heparan sulfate and of
  chondroitin/dermatan sulfate chains, making the disorder a "linkeropathy"
  alongside the XYLT1, XYLT2, B4GALT7 and B3GALT6 disorders. The resulting
  proteoglycan-poor extracellular matrix produces congenital large-joint
  dislocations and contractures, short stature, radioulnar synostosis, reduced
  bone mineral density with fractures in severe cases, characteristic craniofacial
  dysmorphism, and — distinctively among the linkeropathies — congenital cardiac
  valve and great-vessel malformations (bicuspid aortic valve, septal defects,
  mitral valve prolapse, aortic root dilatation). Severity ranges from a mild
  Larsen-like presentation to perinatally lethal disease with craniosynostosis
  and multiple fractures, and correlates in part with whether the variant falls
  in the donor- or acceptor-substrate-binding subdomain of GlcAT-I.
synonyms:
- multiple joint dislocations, short stature, craniofacial dysmorphism, with or
  without congenital heart defects
- JDSCD
- B3GAT3-related linkeropathy
- B3GAT3-related disorder
- GlcAT-I deficiency
- Larsen syndrome, autosomal recessive
disease_term:
  preferred_term: Larsen-like syndrome, B3GAT3 type
  term:
    id: MONDO:0009511
    label: Larsen-like syndrome, B3GAT3 type
parents:
- Skeletal Dysplasia
- Connective Tissue Disorder
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    notes: >-
      A monogenic autosomal recessive inborn error of proteoglycan biosynthesis
      presenting as a multisystem skeletal/connective tissue dysplasia rather
      than as a disorder of a single organ system.
  icimd_category:
  - classification_value: o_linked_protein_glycosylation
    notes: >-
      ICIMD places glycosaminoglycan-linker (proteoglycan O-xylosylglycan)
      synthesis defects under disorders of O-linked protein glycosylation, a
      congenital disorder of glycosylation. MONDO likewise classifies
      MONDO:0009511 as a congenital disorder of glycosylation.
    evidence:
    - reference: PMID:31438591
      reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The LK genes encode for enzymes that add glycosaminoglycan chains onto
        proteoglycans via a common tetrasaccharide linker region.
      explanation: >-
        Identifies the disease class as a defect of glycan (glycosaminoglycan)
        chain addition onto a protein core, i.e. a protein O-glycosylation
        defect.
references:
- reference: PMID:21763480
  title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
- reference: PMID:31438591
  title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
inheritance:
- name: Autosomal Recessive
  description: >
    Biallelic (homozygous or compound heterozygous) pathogenic B3GAT3 variants
    are required. Most reported families are consanguineous and homozygous for a
    founder or private missense allele; compound heterozygosity, including a null
    allele in trans with a hypomorphic missense, has also been documented.
    Heterozygous carrier parents are unaffected.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:34537402
    reference_title: "B3GAT3-related linkeropathy and an in-frame homozygous deletion in an adult patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants in B3GAT3 hence lead to Linkeropathy due to
      loss of function or decreased activity of this enzyme.
    explanation: States explicitly that biallelic variants are required.
  - reference: PMID:34537402
    reference_title: "B3GAT3-related linkeropathy and an in-frame homozygous deletion in an adult patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both unaffected parents (double second cousins) were shown to be
      heterozygous carriers.
    explanation: >-
      Documents unaffected heterozygous carrier parents, the defining pattern of
      autosomal recessive inheritance.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Only 26 molecularly confirmed patients from 13 families had been reported in
    the literature as of the 2019 comprehensive review; a handful of further
    cases have since been published (e.g. a Chinese infant in 2022 and two Turkish
    siblings in 2024). No population prevalence estimate exists.
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Table 2 summarizes the clinical features of the 26 patients from 13
      different families, 11 of which were consanguineous with B3GAT3 mutations
      reported so far
    explanation: >-
      Provides the cumulative published case count, supporting an ultra-rare
      cases-in-literature occurrence measure rather than a population rate.
genetic:
- name: B3GAT3
  notes: >
    B3GAT3 (11q12.3) encodes beta-1,3-glucuronyltransferase 3 /
    glucuronosyltransferase-I (GlcAT-I), a cis- and cis-medial Golgi enzyme that
    transfers UDP-glucuronic acid onto the Gal-Gal-Xyl-Ser trisaccharide,
    completing the tetrasaccharide linker that all glycosaminoglycan chains are
    built upon. Reported disease alleles are predominantly missense substitutions
    in the glycosyltransferase catalytic domain (p.Arg277Gln — the original United
    Arab Emirates founder allele; p.Pro140Leu in the Nias/Indonesia clan;
    p.Gly223Ser in the severe craniosynostosis/fracture phenotype; p.Thr139Met
    recurrent in the Turkish population; p.Pro82Leu in a geroderma-like case;
    p.Arg161Trp and p.Arg297Trp in a compound heterozygote), together with a
    start-loss null allele (p.Met1?), a missense p.Leu224Gln with ~3% residual
    activity, and an in-frame p.Leu21del.
  gene_term:
    preferred_term: B3GAT3
    term:
      id: hgnc:923
      label: B3GAT3
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified linkage to chromosome 11 and detected a mutation
      (c.830G>A, p.Arg277Gln) in B3GAT3, the gene coding for glucuronosyltransferase-I
      (GlcAT-I).
    explanation: >-
      Original gene discovery establishing B3GAT3 as the cause of the Larsen-like
      joint dislocation plus congenital heart defect syndrome.
  - reference: PMID:27871226
    reference_title: "Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Independent in vitro assessment of each variant confirmed the B3GAT3: c.1A > G (p.Met1?)
      variant is functionally null and the c.671 T > A (p.L224Q) missense variant has
      significantly reduced glucuronyltransferase activity (~3% of control).
    explanation: >-
      Functional confirmation that pathogenic B3GAT3 alleles act by loss of
      glucuronyltransferase activity, including a true null allele.
  - reference: PMID:39359951
    reference_title: "A Recurrent c.416C>T Variant in the B3GAT3 Gene in the Turkish Population: Report of Two Siblings and Expanding the Clinical Spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical exome sequencing analysis revealed a homozygous c.416C>T variant
      in the B3GAT3 gene for the sister; the same variant was also present in the
      boy patient.
    explanation: Documents a recurrent homozygous B3GAT3 allele in the Turkish population.
pathophysiology:
- name: GlcAT-I Loss of Function
  biological_scale: MOLECULAR
  description: >
    Biallelic B3GAT3 missense, start-loss, or in-frame deletion variants reduce or
    abolish the galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase
    activity of GlcAT-I. Disease-associated substitutions cluster in the two
    functional halves of the catalytic domain: the donor (UDP-GlcA)
    substrate-binding subdomain (p.Pro140Leu, p.Thr139Met, p.Arg161Trp) and the
    acceptor substrate-binding subdomain (p.Arg277Gln, p.Gly223Ser, p.Leu224Gln,
    p.Arg297Trp). Reduced activity is demonstrable both in patient-derived cells
    and for recombinant mutant protein.
  gene:
    preferred_term: B3GAT3
    term:
      id: hgnc:923
      label: B3GAT3
  molecular_functions:
  - preferred_term: glucuronosyltransferase-I (GlcAT-I) activity
    term:
      id: GO:0015018
      label: galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity
    modifier: DECREASED
  cellular_components:
  - preferred_term: Golgi apparatus
    term:
      id: GO:0005794
      label: Golgi apparatus
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Patients' cells as well as recombinant mutant protein showed reduced
      glucuronyltransferase activity.
    explanation: >-
      Directly demonstrates reduced GlcAT-I catalytic activity as the proximal
      molecular defect.
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Further studies demonstrated that GlcAT-I resides in the cis and
      cis-medial Golgi apparatus and is expressed in the affected tissues, i.e.,
      heart, aorta, and bone.
    explanation: >-
      Localizes the enzyme to the cis/cis-medial Golgi and shows expression in the
      tissues that are clinically affected.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the more severe phenotypes appear to harbor mutations located within the
      acceptor substrate binding subdomain of the catalytic domain of the protein,
      whereas more mildly affected patients seem to have mutations in the donor
      substrate binding subdomain
    explanation: >-
      Supports the subdomain-based genotype-phenotype correlation described for
      this node.
  downstream:
  - target: Incomplete GAG-Protein Tetrasaccharide Linker Assembly
    description: >
      Loss of the terminal glucuronosyl transfer step leaves the linker
      trisaccharide unfinished, so glycosaminoglycan polymerization cannot begin.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:25893793
      reference_title: "Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        We found that Pro140Leu-mutant GlcAT-I cannot efficiently transfer GlcA to
        the linker region trisaccharide.
      explanation: >-
        Shows directly that the mutant enzyme fails to complete the linker
        tetrasaccharide.
- name: Incomplete GAG-Protein Tetrasaccharide Linker Assembly
  biological_scale: MOLECULAR
  description: >
    All glycosaminoglycan chains — heparan sulfate and chondroitin/dermatan
    sulfate alike — are built on a single shared GlcA-Gal-Gal-Xyl tetrasaccharide
    linker attached to a serine of the proteoglycan core protein. GlcAT-I catalyzes
    the final, committing step of linker assembly, so its deficiency is a
    bottleneck upstream of every downstream GAG polymerase and sulfotransferase.
    This shared-bottleneck position is what defines the "linkeropathy" disease class
    and explains why one enzyme defect produces a pleiotropic connective tissue
    phenotype.
  biological_processes:
  - preferred_term: proteoglycan biosynthesis
    term:
      id: GO:0030166
      label: proteoglycan biosynthetic process
    modifier: DECREASED
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Linkeropathies are due to enzymatic defects in the synthesis of the
      common linker region that joins the core proteins to their glycosaminoglycan
      (GAG) side chains.
    explanation: Defines the shared-linker bottleneck that this node represents.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The linker region is completed by the transfer of glucuronic acid (GlcA)
      catalyzed by glucuronosyltransferase I (GlcAT-I encoded by B3GAT3), upon which
      polymerization of the HS or CS/DS chains begins.
    explanation: >-
      States that GlcAT-I completes the linker and that HS and CS/DS polymerization
      is downstream of it.
  downstream:
  - target: Combined Heparan and Chondroitin/Dermatan Sulfate Proteoglycan Deficiency
    description: >
      Because the blocked step is shared, both the heparan sulfate and the
      chondroitin/dermatan sulfate arms of proteoglycan synthesis are reduced
      together rather than one selectively.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:25893793
      reference_title: "Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        This failure results in a partial deficiency of both chondroitin sulfate
        and heparan sulfate chains.
      explanation: Demonstrates the combined, non-selective GAG deficiency.
- name: Combined Heparan and Chondroitin/Dermatan Sulfate Proteoglycan Deficiency
  biological_scale: CELLULAR
  description: >
    Patient fibroblasts and lymphoblastoid cells carry reduced numbers of GAG side
    chains and reduced levels of heparan sulfate, chondroitin sulfate, and dermatan
    sulfate proteoglycans. Proteoglycans are not only structural space-filling ECM
    components but also co-receptors and morphogen reservoirs (FGF, BMP, Wnt,
    Hedgehog), so their simultaneous depletion degrades both the mechanical and the
    signalling functions of the matrix. The b3gat3 zebrafish mutant qualifies this
    picture: there, CS synthesis is virtually abolished while roughly half of
    normal HS output is retained, implying the two arms may not be equally
    sensitive to loss of the shared linker step.
  biological_processes:
  - preferred_term: heparan sulfate proteoglycan biosynthesis
    term:
      id: GO:0015012
      label: heparan sulfate proteoglycan biosynthetic process
    modifier: DECREASED
  - preferred_term: chondroitin sulfate proteoglycan biosynthesis
    term:
      id: GO:0050650
      label: chondroitin sulfate proteoglycan biosynthetic process
    modifier: DECREASED
  cell_types:
  - preferred_term: dermal fibroblast
    term:
      id: CL:0002620
      label: skin fibroblast
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Patient fibroblasts demonstrated decreased levels of dermatan sulfate,
      chondroitin sulfate, and heparan sulfate proteoglycans, indicating that the
      defect in linker synthesis affected all three lines of O-glycanated
      proteoglycans.
    explanation: >-
      Direct patient-cell measurement of the combined DS/CS/HS proteoglycan
      deficiency.
  - reference: PMID:25893793
    reference_title: "Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Moreover, relative numbers of glycosaminoglycan (GAG) side chains were
      decreased in patient cells.
    explanation: Independent confirmation of reduced GAG side-chain occupancy in patient cells.
  - reference: PMID:22869369
    reference_title: "On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In uxs1 and b3gat3 mutant larvae,
      biosynthesis of CS was shown to be virtually abolished, whereas these mutants
      still were capable of synthesizing 50% of the HS produced in control larvae.
    explanation: >-
      Zebrafish b3gat3 mutants show a markedly asymmetric CS-versus-HS deficit,
      qualifying (rather than simply confirming) the balanced reduction inferred
      from human fibroblasts.
  downstream:
  - target: Proteoglycan-Deficient Extracellular Matrix
    description: >
      Loss of GAG-bearing proteoglycans changes the composition and mechanical
      behaviour of the extracellular matrix in connective tissue.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:24668659
      reference_title: "Skeletal dysplasia, global developmental delay, and multiple congenital anomalies in a 5-year-old boy-report of the second family with B3GAT3 mutation and expansion of the phenotype."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        As a major component of the extracellular matrix, proteoglycans influence the
        mechanical properties of connective tissue and play an important role in
        cell-cell and cell-matrix interactions.
      explanation: >-
        Links proteoglycan loss to altered mechanical and adhesive properties of
        connective tissue matrix.
    - reference: PMID:22869369
      reference_title: "On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        impaired CS biosynthesis inhibited formation of the extracellular matrix
        surrounding chondrocytes.
      explanation: >-
        Establishes the causal step from GAG deficiency to failure of pericellular
        extracellular matrix formation around chondrocytes.
- name: Proteoglycan-Deficient Extracellular Matrix
  biological_scale: TISSUE
  description: >
    The proteoglycan-poor matrix is mechanically weaker and signals abnormally in
    the tissues where B3GAT3 is most highly expressed — cartilage, bone, tendon,
    skeletal muscle, heart and aorta. This is the convergence point from which the
    three principal clinical arms of the disease diverge: skeletal, articular, and
    cardiovascular.
  biological_processes:
  - preferred_term: extracellular matrix organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
    modifier: ABNORMAL
  cell_types:
  - preferred_term: fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  - preferred_term: chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  locations:
  - preferred_term: musculoskeletal system
    term:
      id: UBERON:0002204
      label: musculoskeletal system
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Proteoglycans are a major component of extracellular matrix and contribute to
      normal embryonic and postnatal development by ensuring tissue stability and
      signaling functions.
    explanation: >-
      Establishes the dual structural and signalling role of the proteoglycan-bearing
      matrix that is lost here.
  downstream:
  - target: Impaired Skeletal Growth and Bone Mineralization
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >
      Cartilage and bone matrix depend heavily on proteoglycan content, so the
      matrix defect manifests as disproportionate short stature, metaphyseal and
      epiphyseal dysplasia, radioulnar synostosis and low bone mineral density.
    evidence:
    - reference: PMID:21763480
      reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The study shows that reduced GlcAT-I activity impairs skeletal as well as
        heart development
      explanation: States that reduced GlcAT-I activity impairs skeletal development.
  - target: Joint Capsule and Ligament Laxity
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >
      Weakened, proteoglycan-poor periarticular connective tissue permits
      congenital and recurrent large-joint dislocation and, paradoxically, joint
      contracture.
    evidence:
    - reference: PMID:26086840
      reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Linkeropathies are a group of syndromes characterized by short stature,
        radio-ulnar synostosis, decreased bone density, congenital contractures and
        dislocations, joint laxity, broad digits, brachycephaly, small mouth, prominent
        eyes, short or webbed neck, congenital heart defects and mild developmental
        delay.
      explanation: >-
        Lists congenital contractures, dislocations and joint laxity as core
        consequences of the linker defect.
  - target: Impaired Cardiac Valve and Great Vessel Development
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >
      Cardiac cushion and valve morphogenesis and aortic wall assembly are
      proteoglycan-dependent; B3GAT3 is expressed in heart and aorta and is
      relatively more highly expressed in heart than the other linker enzymes,
      which is the leading explanation for why cardiac malformation is the
      distinguishing feature of this linkeropathy.
    evidence:
    - reference: PMID:21763480
      reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The study shows that reduced GlcAT-I activity impairs skeletal as well as
        heart development and results in variable combinations of heart malformations,
        including mitral valve prolapse, ventricular septal defect, and bicuspid aortic
        valve.
      explanation: Directly links the enzyme defect to the spectrum of cardiac malformations.
- name: Impaired Skeletal Growth and Bone Mineralization
  biological_scale: TISSUE
  description: >
    Chondrocyte and osteoblast function in a proteoglycan-poor matrix yields
    disproportionate short stature, metaphyseal flaring and epiphyseal dysplasia,
    radioulnar synostosis, kyphoscoliosis, and reduced bone mineral density that in
    severely affected individuals progresses to generalized osteoporosis with
    multiple fractures. In the most severe (acceptor-subdomain) genotypes the
    cranial sutures fuse prematurely, producing craniosynostosis and an
    Antley-Bixler-like prenatal presentation.
  biological_processes:
  - preferred_term: bone mineralization
    term:
      id: GO:0030282
      label: bone mineralization
    modifier: DECREASED
  - preferred_term: cartilage development
    term:
      id: GO:0051216
      label: cartilage development
    modifier: ABNORMAL
  cell_types:
  - preferred_term: chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  - preferred_term: osteoblast
    term:
      id: CL:0000062
      label: osteoblast
  locations:
  - preferred_term: bone element
    term:
      id: UBERON:0001474
      label: bone element
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a novel B3GAT3-related disorder with
      craniosynostosis and bone fragility, due to a unique homozygous mutation in
      B3GAT3.
    explanation: >-
      Establishes craniosynostosis and bone fragility as part of the severe end of
      the skeletal arm.
  - reference: PMID:27871226
    reference_title: "Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a 4-year-old patient with a severe phenotype
      of osteoporosis, hypotonia, joint laxity, fractures, scoliosis, biscuspid aortic
      valve and myopia
    explanation: >-
      Documents osteoporosis, fractures and scoliosis in a functionally validated
      B3GAT3 patient.
- name: Joint Capsule and Ligament Laxity
  biological_scale: TISSUE
  description: >
    Ligaments, joint capsules and tendons depend on proteoglycan-rich matrix for
    tensile integrity. Their weakening produces the cardinal congenital large-joint
    dislocations (hips, elbows, knees) and generalized joint hypermobility, while
    the same abnormal periarticular tissue also gives rise to fixed joint
    contractures — an unusual coexistence of laxity and contracture that is
    characteristic of B3GAT3 (and B3GALT6) disease among the linkeropathies.
  locations:
  - preferred_term: skeletal joint
    term:
      id: UBERON:0000982
      label: skeletal joint
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We studied five patients with recessive joint dislocations
      and congenital heart defects, including bicuspid aortic valve (BAV) and aortic
      root dilatation.
    explanation: >-
      The founding cohort was ascertained on recessive joint dislocations, anchoring
      this node clinically.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      While joint hypermobility is a common trait of all LKs, joint contractures are
      more frequently observed in patients with B3GAT3 and B3GALT6 mutations.
    explanation: >-
      Supports the coexistence of hypermobility with contractures and its relative
      specificity for B3GAT3.
- name: Impaired Cardiac Valve and Great Vessel Development
  biological_scale: TISSUE
  description: >
    Proteoglycan-rich cardiac jelly and valve interstitial matrix are required for
    endocardial cushion remodelling and semilunar/atrioventricular valve
    morphogenesis, and proteoglycans are structural constituents of the aortic
    media. GlcAT-I deficiency therefore yields bicuspid aortic valve, mitral valve
    prolapse, atrial and ventricular septal defects, and progressive aortic root
    dilatation. Cardiovascular involvement is the feature that most sharply
    distinguishes B3GAT3-related disease from the B4GALT7/B3GALT6 spondylodysplastic
    Ehlers-Danlos linkeropathies, and it is genotype-dependent: the Nias
    p.Pro140Leu donor-subdomain family had no detectable cardiac phenotype.
  biological_processes:
  - preferred_term: heart valve development
    term:
      id: GO:0003170
      label: heart valve development
    modifier: ABNORMAL
  locations:
  - preferred_term: cardiac valve
    term:
      id: UBERON:0000946
      label: cardiac valve
  - preferred_term: aorta
    term:
      id: UBERON:0000947
      label: aorta
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The described family constitutes a syndrome
      characterized by heart defects and joint dislocations resulting from altered
      initiation of proteoglycan synthesis (Larsen-like syndrome, B3GAT3 type).
    explanation: >-
      Attributes the cardiac defects directly to altered initiation of proteoglycan
      synthesis, and names the disease entity.
  - reference: PMID:25893793
    reference_title: "Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      no heart phenotype could be detected in our family.
    explanation: >-
      Qualifies the cardiac arm as genotype-dependent rather than obligate — the
      donor-subdomain p.Pro140Leu Nias family had no heart involvement, in explicit
      contrast to the p.Arg277Gln families.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Concerning cardiovascular involvement, anomalies such as septal defects, aortic
      valve dysplasia, aortic root and ascending aorta dilatation, and mitral valve
      prolapse, are more recurrent in B3GAT3-related disorders as well as in SOS.
    explanation: >-
      Establishes cardiovascular involvement as comparatively characteristic of
      B3GAT3-related disease among the linkeropathies.
mechanistic_hypotheses:
- hypothesis_group_id: subdomain_severity_gradient
  hypothesis_label: Catalytic-subdomain location determines phenotype severity
  status: EMERGING
  description: >
    Across the small published cohort, variants in the acceptor-substrate-binding
    subdomain of the GlcAT-I catalytic domain (p.Gly223Ser, p.Leu224Gln,
    p.Arg277Gln, p.Arg297Trp) segregate with the severe end of the spectrum —
    multiple fractures, craniosynostosis, cardiovascular malformation, and in the
    p.Gly223Ser cases death before one year — whereas donor-subdomain variants
    (p.Pro140Leu, p.Thr139Met, p.Arg161Trp) produce milder, sometimes purely
    skeletal disease. A compound heterozygote carrying one variant in each
    subdomain had an intermediate phenotype. The correlation rests on very few
    patients and is not yet supported by a systematic activity-versus-severity
    assay series, so it should be treated as emerging rather than as an established
    genotype-phenotype rule.
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The heterogeneous LK phenotypes, ranging from mild to severe and even lethal
      presentations, seem to be related to specific B3GAT3 mutations, though there has
      been a limited number of patients and pathogenic variants described so far
    explanation: >-
      States both the genotype-phenotype correlation and the small-sample caveat that
      keeps this hypothesis at EMERGING status.
phenotypes:
- category: Musculoskeletal
  name: Multiple Congenital Joint Dislocations
  description: >
    Congenital and recurrent dislocation of large joints — hips, elbows, knees and
    shoulders — is the cardinal and eponymous ("Larsen-like") feature, present from
    birth and often the presenting sign.
  phenotype_term:
    preferred_term: Joint dislocation
    term:
      id: HP:0001373
      label: Joint dislocation
    temporality: RECURRENT
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We studied five patients with recessive joint dislocations
      and congenital heart defects, including bicuspid aortic valve (BAV) and aortic
      root dilatation.
    explanation: All five patients in the founding cohort had joint dislocations.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The phenotypic features with a high rate of incidence shared among all LKs
      include short stature, joint laxity with dislocations, craniofacial dysmorphism
      (especially prominent forehead/eyes and blue sclerae), pectus abnormalities,
      peculiar fingers, foot deformities, and to a variable degree hypotonia and
      developmental delay.
    explanation: >-
      Supports the VERY_FREQUENT band — dislocations are among the features with a
      high rate of incidence across the linkeropathies including B3GAT3.
- category: Musculoskeletal
  name: Joint Hypermobility
  description: >
    Generalized joint hypermobility, most marked at the metacarpophalangeal,
    interphalangeal and knee joints, coexists with the dislocation tendency.
  phenotype_term:
    preferred_term: Joint hypermobility
    term:
      id: HP:0001382
      label: Joint hypermobility
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      While joint hypermobility is a common trait of all LKs, joint contractures are
      more frequently observed in patients with B3GAT3 and B3GALT6 mutations.
    explanation: >-
      Documents joint hypermobility as a common feature of the linkeropathies
      including B3GAT3.
- category: Musculoskeletal
  name: Joint Contractures
  description: >
    Fixed contractures of both large and small joints — notably limited elbow
    extension and flexion contractures of the fingers — occur alongside the laxity
    and are relatively characteristic of B3GAT3 (and B3GALT6) among the
    linkeropathies.
  phenotype_term:
    preferred_term: Joint contracture
    term:
      id: HP:0034392
      label: Joint contracture
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These patients featured mainly
      craniosynostosis, midface hypoplasia, bilateral radioulnar synostosis, multiple
      neonatal fractures, dislocated joints, joint contracture, long fingers, foot
      deformity, and cardiovascular abnormalities.
    explanation: Lists joint contracture among the core features in six B3GAT3 patients.
- category: Musculoskeletal
  name: Short Stature
  description: >
    Disproportionate short stature with a short trunk and shortened proximal long
    bones is near-universal, often with growth failure from infancy.
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Linkeropathies are a group of syndromes characterized by short stature,
      radio-ulnar synostosis, decreased bone density, congenital contractures and
      dislocations, joint laxity, broad digits, brachycephaly, small mouth, prominent
      eyes, short or webbed neck, congenital heart defects and mild developmental
      delay.
    explanation: Short stature is listed first among the defining linkeropathy features.
  - reference: PMID:24668659
    reference_title: "Skeletal dysplasia, global developmental delay, and multiple congenital anomalies in a 5-year-old boy-report of the second family with B3GAT3 mutation and expansion of the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Short stature is ubiquitous, but possibly more pronounced in the B3GALT6 and
      B4GALT7 mutations.
    explanation: >-
      Explicitly describes short stature as ubiquitous across linkeropathy patients,
      supporting the VERY_FREQUENT band.
- category: Musculoskeletal
  name: Radioulnar Synostosis
  description: >
    Bilateral proximal radioulnar synostosis with dysplastic radial heads and fixed
    forearm rotation is a hallmark radiographic finding and, together with a
    craniosynostotic skull shape, is what prompts a prenatal Antley-Bixler
    suspicion in severe cases.
  phenotype_term:
    preferred_term: Radioulnar synostosis
    term:
      id: HP:0002974
      label: Radioulnar synostosis
  frequency: FREQUENT
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These patients featured mainly
      craniosynostosis, midface hypoplasia, bilateral radioulnar synostosis, multiple
      neonatal fractures, dislocated joints, joint contracture, long fingers, foot
      deformity, and cardiovascular abnormalities.
    explanation: Bilateral radioulnar synostosis in all six patients of this series.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Radioulnar synostosis seems more specific for B3GAT3-and B4GALT7-related
      disorders
    explanation: Identifies radioulnar synostosis as comparatively specific for B3GAT3 disease.
- category: Musculoskeletal
  name: Reduced Bone Mineral Density
  description: >
    Osteopenia progressing to generalized osteoporosis is common and can be severe
    even in childhood, sometimes refractory to bisphosphonate treatment.
  phenotype_term:
    preferred_term: Osteopenia
    term:
      id: HP:0000938
      label: Osteopenia
    clinical_course: PROGRESSIVE
  frequency: FREQUENT
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      like previously reported patients, he had bilateral radio-ulnar
      synostosis, severe osteopenia, an increased gap between first and second toes,
      bilateral club feet, and atrial and ventricular septal defects.
    explanation: Severe osteopenia described as a feature shared with previously reported patients.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Low bone mineral density/osteopenia and radiographic abnormalities are also
      very common
    explanation: Supports the FREQUENT band for low bone mineral density across linkeropathies.
- category: Musculoskeletal
  name: Bone Fragility with Multiple Fractures
  description: >
    In the severe (typically acceptor-subdomain) genotypes, low bone mass is
    accompanied by multiple long-bone fractures, sometimes beginning in the
    neonatal period, mimicking osteogenesis imperfecta.
  phenotype_term:
    preferred_term: Increased susceptibility to fractures
    term:
      id: HP:0002659
      label: Increased susceptibility to fractures
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a novel B3GAT3-related disorder with
      craniosynostosis and bone fragility, due to a unique homozygous mutation in
      B3GAT3.
    explanation: Establishes bone fragility as a documented B3GAT3 phenotype.
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report on a patient with a novel homozygous B3GAT3
      (c.667G>A, p.Gly223Ser) mutation and a history of multiple fractures, blue
      sclerae, and glaucoma.
    explanation: Documents multiple fractures in a p.Gly223Ser homozygote.
- category: Musculoskeletal
  name: Kyphoscoliosis
  description: >
    Progressive kyphoscoliosis can be severe, may fail orthotic management, and has
    required halo-gravity traction followed by posterior instrumented spinal fusion.
  phenotype_term:
    preferred_term: Kyphoscoliosis
    term:
      id: HP:0002751
      label: Kyphoscoliosis
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:39359951
    reference_title: "A Recurrent c.416C>T Variant in the B3GAT3 Gene in the Turkish Population: Report of Two Siblings and Expanding the Clinical Spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The 14-year-old boy exhibited short stature, severe kyphoscoliosis,
      splenomegaly, and aortic root dilatation, along with several physical
      abnormalities including bifid uvula, blue sclera, limited elbow extension, and
      pectus carinatum.
    explanation: Documents severe kyphoscoliosis in a homozygous c.416C>T patient.
  - reference: PMID:34537402
    reference_title: "B3GAT3-related linkeropathy and an in-frame homozygous deletion in an adult patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The disease history includes congenital severe joint
      malalignment of elbows, hips, knees and feet, hypermobility, severe
      kyphoscoliosis, osteoporosis with multiple fractures in childhood, congenital
      diaphragmatic hernia, minor dental anomalies, digital malformations, and
      characteristic facial features.
    explanation: Severe kyphoscoliosis persisting into adult life in a p.Leu21del homozygote.
- category: Musculoskeletal
  name: Craniosynostosis
  description: >
    Premature cranial suture fusion occurs in the severe p.Gly223Ser genotype and,
    combined with radioulnar or radiohumeral synostosis, generates a prenatal
    Antley-Bixler-like appearance.
  phenotype_term:
    preferred_term: Craniosynostosis
    term:
      id: HP:0001363
      label: Craniosynostosis
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Based on prenatal suspicion of the combination of radioulnar or
      radiohumeral synostosis and a peculiar shape of the skull suggestive of
      craniosynostosis, we report on six patients from four unrelated consanguineous
      families in whom Antley-Bixler syndrome was suspected during the prenatal period
    explanation: >-
      Six patients from four families with craniosynostosis; restricted to one severe
      genotype, hence OCCASIONAL rather than a general feature.
- category: Musculoskeletal
  name: Foot Deformity
  description: >
    Bilateral talipes equinovarus (club foot) is common; other reported foot
    anomalies include pes planovalgus, a wide sandal gap and broad toes.
  phenotype_term:
    preferred_term: Talipes equinovarus
    term:
      id: HP:0001762
      label: Talipes equinovarus
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      like previously reported patients, he had bilateral radio-ulnar
      synostosis, severe osteopenia, an increased gap between first and second toes,
      bilateral club feet, and atrial and ventricular septal defects.
    explanation: Documents bilateral club feet and the increased first-second toe gap.
- category: Musculoskeletal
  name: Broad Fingertips
  description: >
    Broad, spatulate distal phalanges of fingers and toes with short nails are a
    recognizable hand finding shared across the linkeropathies.
  phenotype_term:
    preferred_term: Broad fingertip
    term:
      id: HP:0011300
      label: Broad fingertip
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Linkeropathies are a group of syndromes characterized by short stature,
      radio-ulnar synostosis, decreased bone density, congenital contractures and
      dislocations, joint laxity, broad digits, brachycephaly, small mouth, prominent
      eyes, short or webbed neck, congenital heart defects and mild developmental
      delay.
    explanation: Broad digits listed among the defining features.
- category: Musculoskeletal
  name: Arachnodactyly
  description: >
    Long, slender fingers, sometimes with adducted thumbs and overlapping digits,
    contribute to the Marfanoid/Shprintzen-Goldberg-like impression in several
    reported patients.
  phenotype_term:
    preferred_term: Arachnodactyly
    term:
      id: HP:0001166
      label: Arachnodactyly
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He had the
      additional features of bilateral glaucoma, hypertelorism, upturned nose with
      anteverted nares, a small chest, a diaphragmatic hernia, multiple fractures,
      arachnodactyly, overlapping fingers with ulnar deviation, lymphedema, hypotonia,
      hearing loss, and perinatal cerebral infarction
    explanation: Documents arachnodactyly and overlapping fingers.
- category: Musculoskeletal
  name: Pectus Carinatum
  description: Anterior chest wall protrusion, sometimes asymmetric.
  phenotype_term:
    preferred_term: Pectus carinatum
    term:
      id: HP:0000768
      label: Pectus carinatum
  evidence:
  - reference: PMID:39359951
    reference_title: "A Recurrent c.416C>T Variant in the B3GAT3 Gene in the Turkish Population: Report of Two Siblings and Expanding the Clinical Spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      along with several physical
      abnormalities including bifid uvula, blue sclera, limited elbow extension, and
      pectus carinatum.
    explanation: Documents pectus carinatum in a B3GAT3 patient.
- category: Cardiovascular
  name: Bicuspid Aortic Valve
  description: >
    A bicuspid aortic valve is one of the recurrent structural cardiac lesions and
    was present in the original UAE family.
  phenotype_term:
    preferred_term: Bicuspid aortic valve
    term:
      id: HP:0001647
      label: Bicuspid aortic valve
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We studied five patients with recessive joint dislocations
      and congenital heart defects, including bicuspid aortic valve (BAV) and aortic
      root dilatation.
    explanation: Bicuspid aortic valve documented in the founding cohort.
  - reference: PMID:27871226
    reference_title: "Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a 4-year-old patient with a severe phenotype
      of osteoporosis, hypotonia, joint laxity, fractures, scoliosis, biscuspid aortic
      valve and myopia
    explanation: Independent case with bicuspid aortic valve.
- category: Cardiovascular
  name: Aortic Root Dilatation
  description: >
    Progressive dilatation of the aortic root and ascending aorta is a recurrent
    finding and can appear remarkably early — as young as two months of age —
    mandating lifelong echocardiographic surveillance.
  phenotype_term:
    preferred_term: Aortic root dilatation
    term:
      id: HP:0002616
      label: Aortic root aneurysm
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:35151321
    reference_title: "Severe phenotypes of B3GAT3-related disorder caused by two heterozygous variants: a case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our patient was the youngest, at the age of
      2 months, to experience aortic root dilation.
    explanation: Documents the earliest reported onset of aortic root dilatation in this disorder.
  - reference: PMID:39359951
    reference_title: "A Recurrent c.416C>T Variant in the B3GAT3 Gene in the Turkish Population: Report of Two Siblings and Expanding the Clinical Spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The 14-year-old boy exhibited short stature, severe kyphoscoliosis,
      splenomegaly, and aortic root dilatation
    explanation: Independent case with aortic root dilatation in adolescence.
- category: Cardiovascular
  name: Septal Defects
  description: >
    Atrial and ventricular septal defects occur and may require surgical closure;
    one reported patient developed tachyarrhythmia and pulmonary hypertension
    before ASD repair.
  phenotype_term:
    preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      results in variable combinations of
      heart malformations, including mitral valve prolapse, ventricular septal defect,
      and bicuspid aortic valve.
    explanation: Ventricular septal defect named among the recurrent malformations.
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      bilateral club feet, and atrial and ventricular septal defects.
    explanation: Documents both atrial and ventricular septal defects.
- category: Cardiovascular
  name: Mitral Valve Prolapse
  description: Atrioventricular valve prolapse with variable regurgitation.
  phenotype_term:
    preferred_term: Mitral valve prolapse
    term:
      id: HP:0001634
      label: Mitral valve prolapse
  evidence:
  - reference: PMID:21763480
    reference_title: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      results in variable combinations of
      heart malformations, including mitral valve prolapse, ventricular septal defect,
      and bicuspid aortic valve.
    explanation: Mitral valve prolapse named among the recurrent cardiac malformations.
- category: Craniofacial
  name: Hypertelorism
  description: >
    Hypertelorism is one element of a recognizable facial gestalt that can also
    include downslanting palpebral fissures, a short upturned nose with anteverted
    nares, midface hypoplasia, prominent forehead, low-set ears, a high-arched or
    narrow palate, and micrognathia.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He had the
      additional features of bilateral glaucoma, hypertelorism, upturned nose with
      anteverted nares, a small chest, a diaphragmatic hernia, multiple fractures,
      arachnodactyly, overlapping fingers with ulnar deviation, lymphedema, hypotonia,
      hearing loss, and perinatal cerebral infarction
    explanation: Documents hypertelorism and the upturned nose with anteverted nares.
- category: Craniofacial
  name: Midface Hypoplasia
  description: >
    Midface retrusion with a flat face is a frequent and comparatively
    B3GAT3-characteristic craniofacial feature.
  phenotype_term:
    preferred_term: Midface hypoplasia
    term:
      id: HP:0011800
      label: Midface retrusion
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These patients featured mainly
      craniosynostosis, midface hypoplasia, bilateral radioulnar synostosis, multiple
      neonatal fractures, dislocated joints, joint contracture, long fingers, foot
      deformity, and cardiovascular abnormalities.
    explanation: Midface hypoplasia in all six patients of the severe series.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among the plethora of craniofacial dysmorphism, midface hypoplasia,
      craniosynostosis, and short/webbed neck are particularly frequent in
      B3GAT3-related disorders.
    explanation: Identifies midface hypoplasia as particularly frequent in B3GAT3 disease.
- category: Craniofacial
  name: Short Neck
  description: Short or webbed neck with a low posterior hairline.
  phenotype_term:
    preferred_term: Short neck
    term:
      id: HP:0000470
      label: Short neck
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among the plethora of craniofacial dysmorphism, midface hypoplasia,
      craniosynostosis, and short/webbed neck are particularly frequent in
      B3GAT3-related disorders.
    explanation: Short/webbed neck identified as particularly frequent in B3GAT3 disease.
- category: Ophthalmologic
  name: Blue Sclerae
  description: >
    Blue sclerae reflect the thin, proteoglycan-poor scleral connective tissue and,
    with the fracture tendency, contribute to the osteogenesis imperfecta-like
    impression in severe cases.
  phenotype_term:
    preferred_term: Blue sclerae
    term:
      id: HP:0000592
      label: Blue sclerae
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report on a patient with a novel homozygous B3GAT3
      (c.667G>A, p.Gly223Ser) mutation and a history of multiple fractures, blue
      sclerae, and glaucoma.
    explanation: Documents blue sclerae.
  - reference: PMID:39359951
    reference_title: "A Recurrent c.416C>T Variant in the B3GAT3 Gene in the Turkish Population: Report of Two Siblings and Expanding the Clinical Spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      along with several physical
      abnormalities including bifid uvula, blue sclera, limited elbow extension, and
      pectus carinatum.
    explanation: Independent case with blue sclerae.
- category: Ophthalmologic
  name: Glaucoma
  description: >
    Bilateral glaucoma has been reported in the severe p.Gly223Ser genotype;
    refractive errors, amblyopia, strabismus and myopia are more commonly reported
    ocular findings.
  phenotype_term:
    preferred_term: Glaucoma
    term:
      id: HP:0000501
      label: Glaucoma
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He had the
      additional features of bilateral glaucoma, hypertelorism, upturned nose with
      anteverted nares, a small chest, a diaphragmatic hernia, multiple fractures,
      arachnodactyly, overlapping fingers with ulnar deviation, lymphedema, hypotonia,
      hearing loss, and perinatal cerebral infarction
    explanation: >-
      Bilateral glaucoma reported in a single severe case, supporting the OCCASIONAL
      band rather than a core feature.
- category: Neurologic
  name: Hypotonia
  description: >
    Generalized muscular hypotonia, often severe in the neonatal period,
    contributes to delayed motor milestones.
  phenotype_term:
    preferred_term: Muscular hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:27871226
    reference_title: "Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a 4-year-old patient with a severe phenotype
      of osteoporosis, hypotonia, joint laxity, fractures, scoliosis, biscuspid aortic
      valve and myopia
    explanation: Documents hypotonia in a functionally validated B3GAT3 patient.
  - reference: PMID:24668659
    reference_title: "Skeletal dysplasia, global developmental delay, and multiple congenital anomalies in a 5-year-old boy-report of the second family with B3GAT3 mutation and expansion of the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypotonia seems ubiquitous, whereas developmental delay is only present in some
      patients.
    explanation: >-
      Describes hypotonia as ubiquitous across linkeropathy patients, supporting the
      VERY_FREQUENT band.
- category: Neurologic
  name: Developmental Delay
  description: >
    Mild global developmental delay — chiefly motor, with variable speech delay —
    is reported in a subset; cognition is normal in others, so intellectual
    disability is not an obligate feature.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:24668659
    reference_title: "Skeletal dysplasia, global developmental delay, and multiple congenital anomalies in a 5-year-old boy-report of the second family with B3GAT3 mutation and expansion of the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, he also has developmental delay, a refractive
      errors, dental defects, pectus carinatum, and skin abnormalities that have only
      been associated with linkeropathies caused by mutations in B4GALT6 and B4GALT7.
    explanation: Documents developmental delay as a phenotype-expanding finding.
  - reference: PMID:24668659
    reference_title: "Skeletal dysplasia, global developmental delay, and multiple congenital anomalies in a 5-year-old boy-report of the second family with B3GAT3 mutation and expansion of the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypotonia seems ubiquitous, whereas developmental delay is only present in some
      patients.
    explanation: >-
      Explicitly contrasts ubiquitous hypotonia with developmental delay present only
      in some patients, supporting the OCCASIONAL band.
- category: Other
  name: Congenital Diaphragmatic Hernia
  description: >
    Diaphragmatic and abdominal wall hernias (inguinal, umbilical) reflect the
    generalized connective tissue weakness.
  phenotype_term:
    preferred_term: Congenital diaphragmatic hernia
    term:
      id: HP:0000776
      label: Congenital diaphragmatic hernia
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:34537402
    reference_title: "B3GAT3-related linkeropathy and an in-frame homozygous deletion in an adult patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      hypermobility, severe
      kyphoscoliosis, osteoporosis with multiple fractures in childhood, congenital
      diaphragmatic hernia, minor dental anomalies, digital malformations, and
      characteristic facial features.
    explanation: Documents congenital diaphragmatic hernia in an adult B3GAT3 patient.
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a small chest, a diaphragmatic hernia, multiple fractures,
    explanation: Independent case with diaphragmatic hernia.
- category: Otologic
  name: Sensorineural Hearing Loss
  description: Hearing loss has been reported in severely affected individuals.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:26086840
    reference_title: "A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      arachnodactyly, overlapping fingers with ulnar deviation, lymphedema, hypotonia,
      hearing loss, and perinatal cerebral infarction
    explanation: >-
      Hearing loss reported as a novel finding in a single severe case, supporting the
      OCCASIONAL band.
progression:
- phase: Perinatal-lethal severe course
  age_range: Prenatal period to 1 year
  notes: >-
    Patients homozygous for the acceptor-subdomain p.Gly223Ser allele present
    prenatally with craniosynostosis and radioulnar/radiohumeral synostosis and have
    a uniformly fatal course in the first year of life, with multiple neonatal
    fractures, joint dislocations and contractures, and cardiovascular malformation.
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All died before 1 year of
      age.
    explanation: Documents uniform death before age one in the six p.Gly223Ser patients.
- phase: Survival to adulthood in milder genotypes
  age_range: Birth to adulthood
  notes: >-
    Milder genotypes are compatible with survival into adult life, though with
    substantial cumulative morbidity — fixed joint malalignment, severe
    kyphoscoliosis, osteoporosis with childhood fractures, and dental anomalies.
  evidence:
  - reference: PMID:34537402
    reference_title: "B3GAT3-related linkeropathy and an in-frame homozygous deletion in an adult patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Previously described patients of B3GAT3-deficiency were,
      however, all children with phenotypes ranging from prenatal manifestation and
      early lethality to less severe.
    explanation: >-
      Frames this report as the first adult phenotype, establishing that survival to
      adulthood is possible in milder disease.
diagnosis:
- name: Molecular Genetic Testing (Exome/Genome Sequencing)
  description: >
    Diagnosis rests on identification of biallelic pathogenic B3GAT3 variants. In
    practice most patients have been ascertained by trio exome or clinical exome
    sequencing after a clinical diagnosis of Larsen syndrome, spondylodysplastic
    Ehlers-Danlos syndrome, Marfan syndrome, Antley-Bixler syndrome or
    Shprintzen-Goldberg syndrome proved genetically unconfirmed — the phenotypic
    overlap is close enough that B3GAT3 is frequently missed on targeted panels.
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Molecular diagnosis involved whole-exome and gene-panel
      sequencing.
    explanation: Documents the diagnostic modality used.
  - reference: PMID:35151321
    reference_title: "Severe phenotypes of B3GAT3-related disorder caused by two heterozygous variants: a case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We diagnosed a patient with congenital heart defects at an early age
      with a B3GAT3-related disorder instead of Marfan syndrome
    explanation: >-
      Illustrates that molecular testing reclassifies clinically Marfan-suspected
      patients as B3GAT3-related disease.
- name: Glucuronyltransferase Activity Assay
  description: >
    Enzymatic assay of GlcAT-I activity in patient fibroblasts or lymphoblastoid
    cells, and quantification of GAG side-chain occupancy, can support the
    pathogenicity of variants of uncertain significance. This is a research-level
    assay rather than a routine clinical test.
  evidence:
  - reference: PMID:27871226
    reference_title: "Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      demonstrating the patient had a
      decrease both in the protein level of B3GAT3 and in the glucuronyltransferase
      activity when compared to control samples.
    explanation: Demonstrates the assay used to establish variant pathogenicity.
differential_diagnoses:
- name: Larsen Syndrome (FLNB-related)
  disease_term:
    preferred_term: Larsen syndrome
    term:
      id: MONDO:0007875
      label: Larsen syndrome
  description: >
    Classic Larsen syndrome shares congenital large-joint dislocations and
    craniofacial dysmorphism, and is the source of the "Larsen-like" name.
  distinguishing_features:
  - FLNB-Larsen is autosomal dominant, caused by heterozygous missense variants
    clustered in the actin-binding domain and filamin repeats 13-17, whereas B3GAT3
    disease is autosomal recessive.
  - B3GAT3 disease adds radioulnar synostosis, reduced bone mineral density and
    cardiac valve/great-vessel malformations that are not core features of
    FLNB-Larsen.
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among the B3GAT3-related disorders, a LRS-like presentation similar to that of
      our patient was the most common, but more severe phenotypes resembling ABS, SGS,
      and GO have also been reported
    explanation: >-
      States that a Larsen-syndrome-like presentation is the most common B3GAT3
      phenotype, making FLNB-Larsen the primary differential.
- name: Spondylodysplastic Ehlers-Danlos Syndrome
  disease_term:
    preferred_term: spondylodysplastic Ehlers-Danlos syndrome
    term:
      id: MONDO:0007526
      label: Ehlers-Danlos syndrome, spondylodysplastic type
  description: >
    The B4GALT7- and B3GALT6-related linkeropathies are the immediate mechanistic
    neighbours of B3GAT3 disease — they block the two galactosyl transfer steps of
    the same tetrasaccharide linker — and were incorporated into the 2017 EDS
    nosology as spEDS, together with SLC39A13-spEDS.
  distinguishing_features:
  - B3GAT3 disease is deliberately not classified within spEDS in the 2017 EDS
    nosology despite the shared pathogenic mechanism.
  - Cardiovascular malformation and craniosynostosis are more characteristic of
    B3GAT3 disease.
  - Marked skin hyperextensibility, doughy or translucent skin and atrophic scarring
    are more characteristic of spEDS.
  - Platyspondyly, the hallmark of spondylodysplasia, is essentially absent in
    B3GAT3-related disease.
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with B3GAT3, XYLT1, and XYLT2 mutations were also not classified as
      spEDS, even though there is a common pathogenic mechanism and numerous shared
      clinical features.
    explanation: >-
      Confirms that B3GAT3 disease sits outside the spEDS nosologic bucket despite the
      shared mechanism — the key positioning statement for this entry.
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Platyspondyly, a hallmark of “spondylo”-dysplasia, has never been recognized in
      B4GALT7-spEDS and B3GAT3-related disorders
    explanation: Provides the platyspondyly discriminator relative to B3GALT6-spEDS.
- name: CHST3-Related Skeletal Dysplasia
  disease_term:
    preferred_term: spondyloepiphyseal dysplasia with congenital joint dislocations
    term:
      id: MONDO:0007738
      label: spondyloepiphyseal dysplasia with congenital joint dislocations
  description: >
    CHST3-related skeletal dysplasia (also called autosomal recessive Larsen
    syndrome, or humero-spinal dysostosis) is the closest recessive phenocopy:
    congenital large-joint dislocations, short stature and clubfoot in an
    autosomal recessive glycosaminoglycan-pathway disorder.
  distinguishing_features:
  - CHST3 encodes carbohydrate sulfotransferase 3 (C6ST-1), which 6-O-sulfates
    already-polymerized chondroitin — a downstream chain-modification step, not the
    shared tetrasaccharide linker that B3GAT3 completes, so heparan sulfate
    synthesis is spared.
  - CHST3 disease is dominated by progressive spinal and epiphyseal involvement and
    does not carry the B3GAT3 pattern of radioulnar synostosis with congenital
    cardiac valve and great-vessel malformation.
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The linker region is completed by the transfer of glucuronic acid (GlcA)
      catalyzed by glucuronosyltransferase I (GlcAT-I encoded by B3GAT3), upon which
      polymerization of the HS or CS/DS chains begins.
    explanation: >-
      Establishes that B3GAT3 acts at the shared linker step upstream of chain
      polymerization and its sulfotransferase modifications — the mechanistic boundary
      distinguishing it from a CHST3 chain-sulfation defect. Supports the mechanism
      contrast only; the clinical CHST3 comparison is not asserted from this source.
- name: Antley-Bixler Syndrome
  disease_term:
    preferred_term: Antley-Bixler syndrome
    term:
      id: MONDO:0008803
      label: Antley-Bixler syndrome
  description: >
    The prenatal combination of craniosynostosis with radiohumeral or radioulnar
    synostosis is the classic Antley-Bixler presentation and is exactly what the
    severe p.Gly223Ser B3GAT3 genotype mimics.
  distinguishing_features:
  - Antley-Bixler syndrome is caused by FGFR2 or POR variants; the severe B3GAT3
    patients were negative for the known Antley-Bixler genes.
  - B3GAT3 patients additionally show multiple neonatal fractures, joint
    dislocations and cardiovascular abnormalities.
  evidence:
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This syndrome should be considered in the prenatal period in light of
      the severe outcome and as an alternative diagnosis to Antley-Bixler or
      Shprintzen-Goldberg syndrome.
    explanation: >-
      Explicitly recommends B3GAT3 disease as a prenatal alternative diagnosis to
      Antley-Bixler and Shprintzen-Goldberg syndromes.
  - reference: PMID:28771243
    reference_title: "B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we report on six patients from four unrelated consanguineous
      families in whom Antley-Bixler syndrome was suspected during the prenatal period
      without mutation in genes known to be associated with the
      syndrome.
    explanation: >-
      Documents that the B3GAT3 patients were negative for the known Antley-Bixler
      genes.
- name: Shprintzen-Goldberg Syndrome
  disease_term:
    preferred_term: Shprintzen-Goldberg syndrome
    term:
      id: MONDO:0008426
      label: Shprintzen-Goldberg syndrome
  description: >
    Postnatally the association of craniosynostosis with arachnodactyly and a
    Marfanoid habitus suggests Shprintzen-Goldberg syndrome; at least one B3GAT3
    patient carried that clinical label for years before molecular diagnosis.
  distinguishing_features:
  - Shprintzen-Goldberg syndrome characteristically includes intellectual
    disability and brain anomalies, both absent in the B3GAT3 patient who had been
    misdiagnosed as SGS.
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Interestingly, our patient received a diagnosis of SGS in infancy, though there
      was the absence of several cardinal features, above all intellectual disability
      and brain abnormalities.
    explanation: >-
      Documents the SGS misdiagnosis and the absent cardinal SGS features that
      distinguish it.
- name: Marfan Syndrome
  disease_term:
    preferred_term: Marfan syndrome
    term:
      id: MONDO:0007947
      label: Marfan syndrome
  description: >
    Arachnodactyly with aortic root dilatation in an infant readily suggests Marfan
    syndrome, and a B3GAT3 patient was so labelled at birth.
  distinguishing_features:
  - Marfan syndrome is autosomal dominant and FBN1-related, with tall stature and
    ectopia lentis.
  - B3GAT3 patients have short stature, congenital joint dislocations, radioulnar
    synostosis and reduced bone mineral density.
  evidence:
  - reference: PMID:35151321
    reference_title: "Severe phenotypes of B3GAT3-related disorder caused by two heterozygous variants: a case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report for the first time two heterozygous
      variants of B3GAT3 in a Chinese infant, in whom Marfan syndrome was suspected at
      birth.
    explanation: Documents the Marfan misdiagnosis that molecular testing corrected.
- name: Geroderma Osteodysplastica
  disease_term:
    preferred_term: geroderma osteodysplastica
    term:
      id: MONDO:0009271
      label: geroderma osteodysplastica
  description: >
    A geroderma osteodysplastica-like presentation with cutis laxa, generalized
    osteoporosis with fractures and spondyloepimetaphyseal dysplasia has been
    reported with the homozygous B3GAT3 p.Pro82Leu allele.
  distinguishing_features:
  - Geroderma osteodysplastica proper is caused by GORAB variants; the B3GAT3
    phenocopy is distinguished molecularly rather than clinically.
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      reported a GO–like syndrome in a patient carrying the
      homozygous c.245C>T, p.(Pro82Leu) missense variant in the donor substrate binding
      subdomain of the protein.
    explanation: Documents the geroderma osteodysplastica-like B3GAT3 presentation.
treatments:
- name: Orthopedic and Spinal Surgery
  description: >
    Management is entirely supportive; no disease-modifying therapy exists. Severe
    progressive kyphoscoliosis has been managed with preoperative halo-gravity
    traction followed by posterior instrumentation and spinal fusion. Joint
    dislocations, foot deformity and cervical instability are addressed by
    conventional orthopedic means, with the caveat that surgical results are often
    unsatisfactory in this connective tissue context.
  treatment_term:
    preferred_term: orthopedic surgical procedure
    term:
      id: NCIT:C16186
      label: Orthopedic Surgical Procedure
  therapeutic_modality: SURGERY
  target_phenotypes:
  - preferred_term: Kyphoscoliosis
    term:
      id: HP:0002751
      label: Kyphoscoliosis
  evidence:
  - reference: PMID:39359951
    reference_title: "A Recurrent c.416C>T Variant in the B3GAT3 Gene in the Turkish Population: Report of Two Siblings and Expanding the Clinical Spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The boy underwent preoperative halo-gravity
      traction for severe kyphoscoliosis, followed by posterior instrumentation and
      fusion surgery without complications.
    explanation: Documents the spinal surgical approach used and its uncomplicated outcome.
- name: Bisphosphonate Therapy for Low Bone Mineral Density
  description: >
    Bisphosphonates have been used for the osteopenia/osteoporosis of B3GAT3
    disease, but the reported outcomes are equivocal — one patient remained severely
    osteopenic with delayed bone age despite treatment. Evidence is anecdotal and no
    controlled data exist.
  treatment_term:
    preferred_term: bisphosphonate pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  therapeutic_modality: SMALL_MOLECULE
  target_phenotypes:
  - preferred_term: Osteopenia
    term:
      id: HP:0000938
      label: Osteopenia
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      DEXA confirmed severe osteopenia and delayed bone age despite bisphosphonates
      treatment; no fractures were reported.
    explanation: >-
      Documents bisphosphonate use but with persistent severe osteopenia, so support
      for benefit is only partial.
- name: Cardiovascular Surveillance and Surgical Repair
  description: >
    Lifelong echocardiographic surveillance for valve disease and progressive aortic
    root/ascending aortic dilatation is warranted given the early onset reported
    (from two months of age), with surgical closure of haemodynamically significant
    septal defects. One reported patient required surgical ASD closure after
    developing tachyarrhythmia and pulmonary hypertension.
  treatment_term:
    preferred_term: cardiac surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  therapeutic_modality: SURGERY
  target_phenotypes:
  - preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
  - preferred_term: Aortic root dilatation
    term:
      id: HP:0002616
      label: Aortic root aneurysm
  evidence:
  - reference: PMID:31438591
    reference_title: "Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At the age of two, a heart ultrasound revealed an atrial septal defect, which was
      surgically treated three years later due to tachyarrhythmia and pulmonary
      hypertension.
    explanation: Documents surgical repair of a septal defect prompted by complications.
- name: Genetic Counseling
  description: >
    Autosomal recessive inheritance implies a 25% recurrence risk for siblings.
    Counseling is particularly relevant given the high proportion of consanguineous
    families, the availability of recurrent founder alleles for targeted testing
    (p.Arg277Gln in the United Arab Emirates, p.Thr139Met in Turkey, p.Pro140Leu on
    Nias), and the prenatal detectability of the severe craniosynostosis/synostosis
    phenotype on ultrasound.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:34537402
    reference_title: "B3GAT3-related linkeropathy and an in-frame homozygous deletion in an adult patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both unaffected parents (double second cousins) were shown to be
      heterozygous carriers.
    explanation: >-
      Confirms carrier status of consanguineous parents, the basis for recurrence-risk
      counseling.
animal_models:
- species: Danio rerio (zebrafish)
  genotype: b3gat3 mutant
  category: Skeletal
  genes:
  - preferred_term: B3GAT3
    term:
      id: hgnc:923
      label: B3GAT3
  description: >
    The b3gat3 zebrafish mutant is the only well-characterized animal model of
    GlcAT-I deficiency. It develops abnormal pharyngeal cartilage morphology with
    failure of pericellular extracellular matrix formation around chondrocytes,
    recapitulating the cartilage arm of the human disease. Biochemically the model
    is informative but not a straightforward mirror of the human data: chondroitin
    sulfate biosynthesis is virtually abolished while about half of normal heparan
    sulfate output persists, whereas human patient fibroblasts show a more balanced
    reduction across dermatan, chondroitin and heparan sulfate proteoglycans. The
    model has not been reported to reproduce the human cardiac valve and
    great-vessel malformations.
  evidence:
  - reference: PMID:22869369
    reference_title: "On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      uxs1 and b3gat3 mutants, predicted to have
      impaired biosynthesis of both HS and CS because of defective formation of the
      common proteoglycan linkage tetrasaccharide were analyzed
    explanation: >-
      Identifies the zebrafish b3gat3 mutant as a linker-region-deficient model
      matching the human molecular lesion.
  - reference: PMID:22869369
    reference_title: "On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      impaired CS biosynthesis inhibited formation of the extracellular matrix
      surrounding chondrocytes.
    explanation: >-
      Provides the cartilage-specific mechanistic readout — loss of pericellular
      extracellular matrix around chondrocytes.
discussions:
- discussion_id: b3gat3_cardiac_tissue_specificity
  kind: KNOWLEDGE_GAP
  prompt: >-
    Does the tissue-specific expression level of B3GAT3 relative to the other
    linker enzymes explain why cardiac malformation is characteristic of
    B3GAT3-related disease but not of B4GALT7/B3GALT6 spondylodysplastic EDS?
  attaches_to:
  - pathophysiology#Impaired Cardiac Valve and Great Vessel Development
  rationale: >-
    The leading explanation for the cardiac specificity is that B3GAT3 is expressed
    more highly in heart than B3GALT6 and B4GALT7, so heart tissue is
    disproportionately sensitive to loss of this particular linker step. An
    alternative model holds that the linker enzymes act within a shared complex (a
    "GAGosome"), which would predict comparable rather than differential tissue
    sensitivity. Neither model has been tested directly in cardiac tissue, and the
    observation that the donor-subdomain p.Pro140Leu family had no cardiac phenotype
    at all suggests residual activity thresholds may matter as much as expression
    level.
  proposed_experiments:
  - experiment_id: linker_enzyme_expression_map
    name: Comparative linker-enzyme expression and activity mapping
    description: >-
      Quantify B3GAT3, B4GALT7 and B3GALT6 expression and GlcAT-I / GalT-I / GalT-II
      activity across human developing cardiac valve, aortic media, cartilage and
      bone to test whether cardiac tissue is disproportionately B3GAT3-dependent.
  - experiment_id: tissue_resolved_gag_quantification
    name: Tissue-resolved GAG quantification in linker-enzyme-deficient models
    description: >-
      Measure heparan and chondroitin/dermatan sulfate content in cardiac valve
      tissue from B3GAT3-deficient versus B4GALT7-deficient models to test
      differential tissue sensitivity.
  - experiment_id: glcat1_allelic_series_threshold
    name: Allelic-series threshold test in a vertebrate model
    description: >-
      Establish an allelic series (null, p.Gly223Ser, p.Pro140Leu) in a vertebrate
      model and test whether cardiac cushion phenotypes track residual GlcAT-I
      activity thresholds rather than pathway identity.
- discussion_id: linkeropathy_nosology_boundary
  kind: KNOWLEDGE_GAP
  prompt: >-
    Should B3GAT3-related disease remain a separate nosologic entity, or be merged
    into a single gene-prefixed "linkeropathy" spectrum alongside XYLT1/XYLT2,
    B4GALT7 and B3GALT6 disorders?
  attaches_to:
  - pathophysiology#Incomplete GAG-Protein Tetrasaccharide Linker Assembly
  rationale: >-
    All five linker enzymes act sequentially on the same tetrasaccharide and produce
    overlapping phenotypes, yet the 2017 EDS nosology admits only B4GALT7 and
    B3GALT6 (as spEDS) and leaves B3GAT3, XYLT1 and XYLT2 outside. The comprehensive
    2019 review argues these are a phenotypic continuum and proposes gene-prefixed
    "linkeropathy" naming. dismech currently follows MONDO and keeps this entry
    separate from Spondylodysplastic Ehlers-Danlos Syndrome; a linkeropathy Grouping
    would be the natural way to represent the union without collapsing the entities.
  proposed_experiments:
  - experiment_id: cross_gene_linkeropathy_phenotyping
    name: Cross-gene linkeropathy deep phenotyping cohort
    description: >-
      Systematically phenotype a multi-gene linkeropathy cohort with a common
      instrument to test whether gene identity or residual enzyme activity better
      predicts the clinical profile.
  - experiment_id: linkeropathy_grouping_curation
    name: Curate a dismech linkeropathy Grouping
    description: >-
      Build a dismech Grouping over the linkeropathy entries with explicit
      membership criteria so the boundary between spEDS and the non-spEDS
      linkeropathies is auditable.
- discussion_id: b3gat3_zebrafish_cs_hs_asymmetry
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    Does the zebrafish b3gat3 mutant's near-complete loss of chondroitin sulfate with
    retained heparan sulfate reflect human GlcAT-I deficiency, where patient
    fibroblasts show a more balanced reduction of dermatan, chondroitin and heparan
    sulfate proteoglycans?
  attaches_to:
  - pathophysiology#Combined Heparan and Chondroitin/Dermatan Sulfate Proteoglycan Deficiency
  rationale: >-
    Both systems block the same shared linker step, so a priori both GAG arms should
    fall together — and that is what human fibroblast measurements show. The
    zebrafish model instead shows CS virtually abolished with ~50% of HS retained,
    implying a species- or context-dependent prioritization of HS over CS when linker
    flux is limiting. This matters mechanistically: if the human disease also
    preferentially spares HS, then the skeletal/cartilage phenotype (CS-dependent
    pericellular matrix) should dominate over HS-dependent morphogen-signalling
    phenotypes, which is broadly what is observed clinically. The mismatch is
    unresolved because the human data are semi-quantitative and come from fibroblasts
    rather than cartilage or cardiac tissue.
  proposed_experiments:
  - experiment_id: human_cs_hs_ratio_disease_tissue
    name: Quantitative CS/HS ratio in human B3GAT3 patient tissue
    description: >-
      Measure absolute chondroitin/dermatan sulfate and heparan sulfate chain
      abundance in patient-derived chondrocytes and iPSC-derived cardiac cells, not
      only dermal fibroblasts, to test whether the zebrafish CS-over-HS asymmetry
      holds in human disease-relevant cell types.
  - experiment_id: humanized_allele_zebrafish_rescue
    name: Humanized allele rescue in the zebrafish model
    description: >-
      Test whether human B3GAT3 disease alleles rescue the zebrafish b3gat3 cartilage
      phenotype in an allele-strength-dependent manner, and whether rescue restores
      chondroitin and heparan sulfate proportionately.
notes: >
  Naming decision: the entry is titled "Larsen-like Syndrome B3GAT3 Type" to match
  the canonical MONDO:0009511 label and the curation issue, with "B3GAT3-related
  linkeropathy" / "B3GAT3-related disorder" and the OMIM/Orphanet descriptive name
  (JDSCD) carried as synonyms. The literature is split — Ritelli et al.
  (PMID:31438591) argue for gene-prefixed linkeropathy naming — but MONDO alignment
  is the governing convention here and the eponymic name remains the one most
  readers will search for.

  Scope boundaries. This entry deliberately does NOT cover: (a) classic Larsen
  syndrome, the dominant FLNB disorder curated separately as Larsen_Syndrome
  (MONDO:0007875); (b) the B4GALT7/B3GALT6/SLC39A13 spondylodysplastic Ehlers-Danlos
  syndromes, curated separately as Spondylodysplastic_Ehlers-Danlos_Syndrome
  (MONDO:0007526); or (c) CHST3-related skeletal dysplasia (MONDO:0007738), a
  downstream chondroitin 6-O-sulfotransferase defect rather than a linker-region
  defect. All three are captured as differential diagnoses instead.

  Not curated for lack of verifiable evidence: (i) PMID:29318063 reports short
  stature, growth hormone deficiency and ketotic hypoglycaemia with a
  *heterozygous* B3GAT3 splice variant; because the disorder is autosomal recessive
  and the report does not establish a second allele, that case is not used to
  support disease phenotypes here. (ii) Quantitative GAG figures surfaced by the
  Edison deep-research run (GlcAT-I activity ~3-5% of control; CS ~65% and HS ~53%
  of control in p.Arg277Gln fibroblasts) come from the body of PMID:21763480, which
  is cached abstract-only, so they could not be snippet-verified and are not
  asserted. (iii) Numeric phenotype frequencies are unavailable for most features —
  the cumulative published cohort is ~26 patients — so `frequency:` is populated
  only where a source states a qualitative frequency ("ubiquitous", "very common",
  "high rate of incidence", "present only in some patients") that maps cleanly onto
  the enum, and omitted elsewhere. (iv) No prevalence rate is asserted; the
  Prevalence record uses CASES_IN_LITERATURE with the published case count.
  (v) There is no GeneReviews chapter for B3GAT3 or for Larsen-like syndrome
  B3GAT3 type (PubMed search for "B3GAT3 GeneReviews" returned no results), so the
  GeneReviews phenotype-baseline step could not be applied.

  Deep research: Edison (falcon) run at
  research/Larsen-like_Syndrome_B3GAT3_Type-deep-research-falcon.md. Its report
  independently confirmed MONDO:0009511 / OMIM 245600 / B3GAT3 (NEC preflight
  passed) and contributed the zebrafish b3gat3 model lead (PMID:22869369) and the
  CHST3 differential. Every PMID it cited was independently fetched and every
  snippet used here was verified against the cached abstract.

📚

References & Deep Research

References

2

PMID:21763480

Faulty initiation of proteoglycan synthesis causes cardiac and joint defects.

No top-level findings curated for this source.

PMID:31438591

Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes.

No top-level findings curated for this source.

Deep Research

1

Falcon ▸

Disease Characteristics Research Template

Edison Scientific Literature 23 citations 2026-08-01T17:17:11.761340

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

Disease Name: Larsen-like Syndrome B3GAT3 Type
MONDO ID: (if available)
Category: Mendelian

Research Objectives

Please provide a comprehensive research report on Larsen-like Syndrome B3GAT3 Type covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.

1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

What is the disease? Provide a concise overview.
What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
What are the common synonyms and alternative names?
Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
Risk Factors:

Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases
Genetic risk factors (causal variants, susceptibility loci, modifier genes)
Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
Protective Factors:

Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases
Genetic protective factors (protective variants, modifier alleles)
Environmental protective factors (diet, lifestyle, exposures that reduce risk)
Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene
Pathogenic Variants:
Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
Variant type/class (missense, frameshift, nonsense, splice-site, structural)
Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
Functional consequences (loss of function, gain of function, dominant negative)
Modifier Genes: Genes that modify disease severity or expression
Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases
Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

Search first: CDC databases, WHO, PubMed, NHANES
Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc
Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

Search first: Gene Ontology (GO), Reactome, KEGG, PubMed
Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold
Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA
Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

Search first: ImmPort, Immunome Database, IEDB, Gene Ontology
Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

Search first: PubMed, Gene Ontology, Reactome
Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

Search first: BRENDA, UniProt, KEGG, OMIM, PubMed
Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Molecular Profiling (if available):
Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
Advanced Technologies (if applicable):
Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

Organ Level:
Primary organs directly affected
Secondary organ involvement (complications, secondary effects)
Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT
Tissue and Cell Level:
Specific tissue types affected (epithelial, connective, muscle, nervous)
Specific cell populations targeted (with Cell Ontology terms)

Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB
Subcellular Level:
Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas
Localization:
Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

Onset:
Typical age of onset (congenital, pediatric, adult, geriatric)
Onset pattern (acute, subacute, chronic, insidious)

Search first: OMIM, Orphanet, HPO, PubMed
Progression:
Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
Progression rate (rapid, slow, variable)
Disease course pattern (episodic, relapsing-remitting, progressive, stable)
Disease duration (self-limited, chronic lifelong)

Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM
Patterns:
Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

Epidemiology:
Prevalence (cases per 100,000 at given time)
Incidence (new cases per 100,000 per year)

Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries
For Genetic Etiology:
Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
Population Demographics:
Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
Geographic distribution of specific variants
Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

Clinical Tests:
Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
Genetic Testing:

Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen
Overview of recommended genetic testing approach
Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
FISH > Search first: ClinVar, cytogenetics databases, PubMed
Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
Omics-Based Diagnostics (if applicable):
RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
Clinical Criteria:
Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
Screening:
Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

Survival and Mortality:
Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
Morbidity and Function:
Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
Disease Course:
Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
Prediction:
Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

Pharmacotherapy:
Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
Advanced Therapeutics:
Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
Surgical and Interventional:
Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
Supportive and Rehabilitative:
Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
Experimental:
Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
Treatment Outcomes:
Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
Treatment Strategy:
Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest NCIT (NCI Thesaurus) clinical-intervention terms where applicable.

13. Prevention

Prevention Levels:
Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
Immunization: Vaccine strategies (if applicable)

Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database
Screening and Early Detection:
Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
Behavioral Interventions: Lifestyle modifications to reduce risk

Search first: CDC, WHO, behavioral intervention databases, Cochrane Library
Counseling: Genetic counseling (risk assessment, family planning guidance)

Search first: NSGC resources, ACMG guidelines, GeneReviews
Public Health:
Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
Prophylaxis: Preventive medications or procedures

Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

Taxonomy: Species affected (with NCBI Taxon identifiers)

Search first: NCBI Taxonomy
Breed: Specific breeds affected (with VBO identifiers if applicable)

Search first: VBO (Vertebrate Breed Ontology)
Gene: Orthologous genes in other species (with NCBI Gene IDs)

Search first: NCBI Gene
Natural Disease:
Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
Comparative Biology:
Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
Transmission (if applicable):
Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

Model Types:
Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
Genetic Models:
Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
Model Characteristics:
Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
Applications:
Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
Resources:
Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

Cite primary literature (PMID preferred) for all mechanistic and clinical claims
Prioritize recent reviews and landmark papers
Include direct quotes from abstracts where possible to support key statements
Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, NCIT, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (NCIT terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

Larsen-like syndrome, B3GAT3 type: comprehensive disease-characteristics report

Executive summary and evidence limits

Larsen-like syndrome, B3GAT3 type is an ultra-rare autosomal-recessive glycosaminoglycan (GAG) linkeropathy caused by biallelic pathogenic variants in B3GAT3. It is best regarded as a phenotypic continuum—also called B3GAT3-related disorder—rather than a narrowly uniform syndrome. Cardinal manifestations are congenital skeletal dysplasia, joint laxity and dislocations, contractures or radioulnar synostosis, short stature, craniofacial dysmorphism, osteopenia or fractures, and variable congenital cardiovascular disease. Severe alleles can cause craniosynostosis, marked bone fragility, and death in infancy. (baasanjav2011faultyinitiationof pages 2-3, yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 10-12)

The evidence base is exceptionally small. The 2019 synthesis comprised approximately 26 patients from 13 families, 11 reportedly consanguineous. Consequently, frequencies below are descriptive counts from variant-stratified case series, not stable population estimates. Most knowledge comes from individual patients and pedigrees rather than EHR cohorts, registries, randomized trials, or epidemiologic surveillance. (ritelli2019furtherdefiningthe pages 10-12)

Domain	Evidence-backed finding	Suggested ontology/identifier	Evidence type/limitations
Disease identifiers / nomenclature	Rare autosomal recessive linkeropathy caused by biallelic B3GAT3 variants; originally proposed as “Larsen-like syndrome, B3GAT3 type” and now often grouped under B3GAT3-related disorder/linkeropathy. MONDO association available. OMIM phenotype cited in review literature as 245600. (OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3, baasanjav2011faultyinitiationof pages 2-3, ritelli2019furtherdefiningthe pages 10-12)	MONDO:0009511; OMIM:245600; disease label: Larsen-like syndrome, B3GAT3 type	Aggregated disease-resource plus primary case reports/reviews; naming varies across papers and severity spectrum overlaps ABS/SGS/GO-like presentations.
Evidence provenance	Knowledge derives from aggregated disease-level literature and curated resources, but core evidence is from individual case reports/series and small family-based cohorts, not EHR-scale datasets. (baasanjav2011faultyinitiationof pages 2-3, ritelli2019furtherdefiningthe pages 10-12, ritelli2019furtherdefiningthe pages 1-3)	Evidence type labels: human case report; family study; review	Very small sample sizes; ascertainment and publication bias likely.
Causal gene	B3GAT3 encodes beta-1,3-glucuronyltransferase 3 / GlcAT-I, the enzyme that adds the terminal glucuronic acid of the common proteoglycan linker tetrasaccharide. (OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3, baasanjav2011faultyinitiationof pages 2-3, mizumoto2018defectsinbiosynthesis pages 9-10)	HGNC gene symbol: B3GAT3; protein label: GlcAT-I	Strong gene-disease validity from multiple families, functional assays, and curated target-disease association.
Inheritance	Autosomal recessive inheritance with affected individuals typically carrying biallelic variants; many reported families are consanguineous. (baasanjav2011faultyinitiationof pages 2-3, yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 10-12)	Inheritance term: autosomal recessive	Based on small pedigrees; penetrance appears high for biallelic pathogenic variants but is not formally quantified.
Pathogenic variant spectrum	Reported variants include homozygous c.830G>A p.Arg277Gln, c.419C>T p.Pro140Leu, c.416C>T p.Thr139Met, c.245C>T p.Pro82Leu, c.667G>A p.Gly223Ser, and compound heterozygous c.1A>G p.Met1? / c.671T>A p.Leu224Gln; most are missense/hypomorphic. (ritelli2019furtherdefiningthe pages 8-10, ritelli2019furtherdefiningthe pages 10-12)	Variant class labels: missense; start-loss; compound heterozygous; homozygous	Review synthesis included ~26 patients/13 families; some variants lacked direct fibroblast functional testing.
Core mechanism	B3GAT3 deficiency impairs completion of the Xyl-Gal-Gal-GlcA linker region, disrupting synthesis of chondroitin sulfate (CS), dermatan sulfate (DS), and heparan sulfate (HS) chains on proteoglycans. Patient fibroblasts showed markedly reduced GlcAT-I activity and reduced surface GAG chains. (baasanjav2011faultyinitiationof pages 2-3, mizumoto2018defectsinbiosynthesis pages 9-10, baasanjav2011faultyinitiationof pages 8-10, baasanjav2011faultyinitiationof pages 6-7)	GO: glycosaminoglycan biosynthetic process; proteoglycan biosynthetic process; Golgi apparatus	Direct biochemical evidence exists for p.Arg277Gln; mechanistic extrapolation to some later variants is partly review-based.
Protein dysfunction / subcellular localization	GlcAT-I normally localizes to the cis/cis-medial Golgi; mutant p.Arg277Gln showed reduced protein abundance, loss of normal Golgi localization, and residual activity consistent with a hypomorphic loss-of-function effect. (baasanjav2011faultyinitiationof pages 6-7)	GO cellular component: cis-Golgi network / Golgi apparatus	Directly shown for one variant in fibroblasts/recombinant assays; not established for every allele.
Functional quantitative data	In patient fibroblasts with p.Arg277Gln, GlcAT-I activity was reduced to ~3–5% of control, with CS chains ~65% and HS chains ~53% of control levels. (baasanjav2011faultyinitiationof pages 6-7, baasanjav2011faultyinitiationof pages 8-10)	Laboratory phenotype labels: reduced glucuronyltransferase activity; decreased cell-surface CS/HS	Single-family biochemical dataset; no standardized clinical biomarker thresholds.
Genotype-phenotype correlation	Severity appears to vary by variant/domain: p.Gly223Ser is associated with a particularly severe infantile craniosynostosis/bone fragility phenotype; p.Pro140Leu may have prominent skeletal disease with less cardiac involvement. (yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 10-12, mizumoto2018defectsinbiosynthesis pages 9-10)	Genotype-phenotype association label	Correlations are suggestive only because each genotype is represented by very few patients.
Major phenotype group: skeletal / joints	Core musculoskeletal findings include short stature, joint hypermobility/laxity, multiple joint dislocations, elbow abnormalities, radioulnar synostosis, foot deformity, kyphoscoliosis/scoliosis, osteopenia, and sometimes fractures. (baasanjav2011faultyinitiationof pages 2-3, yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 14-16, ritelli2019furtherdefiningthe pages 8-10)	HPO suggestions: Short stature; Joint hypermobility; Joint dislocation; Radioulnar synostosis; Scoliosis; Kyphosis; Osteopenia; Fractures; Talipes/clubfoot	Frequencies in reviews are variant-stratified and tiny; pooled percentages are unstable.
Major phenotype group: craniofacial	Frequent craniofacial features include midface hypoplasia, depressed nasal bridge, micrognathia, downslanting palpebral fissures, short/webbed neck, blue sclerae, prominent/proptotic eyes, and in severe cases craniosynostosis. (baasanjav2011faultyinitiationof pages 2-3, yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 14-16, ritelli2019furtherdefiningthe pages 8-10)	HPO suggestions: Midface retrusion/hypoplasia; Depressed nasal bridge; Micrognathia; Downslanting palpebral fissures; Blue sclerae; Craniosynostosis; Webbed neck	Some features are concentrated in severe allelic subsets rather than universal across B3GAT3 disease.
Major phenotype group: cardiovascular	Cardiovascular involvement is a notable distinguishing feature, including bicuspid aortic valve, mitral valve prolapse, septal defects, aortic root dilatation, and broader congenital heart disease. (baasanjav2011faultyinitiationof pages 2-3, ritelli2019furtherdefiningthe pages 3-5, ritelli2019furtherdefiningthe pages 14-16)	HPO suggestions: Bicuspid aortic valve; Mitral valve prolapse; Atrial septal defect; Aortic root dilatation; Congenital heart defect	Cardiac burden appears enriched relative to some other linkeropathies, but exact prevalence remains uncertain.
Major phenotype group: connective tissue / skin / other	Additional reported findings include pectus abnormality, peculiar fingers (long/slender/tapered/broad/arachnodactylous), hypotonia, low bone mineral density, ophthalmic abnormalities, and occasional developmental delay; cognition may be normal in some families. (ritelli2019furtherdefiningthe pages 3-5, ritelli2019furtherdefiningthe pages 14-16, ritelli2019furtherdefiningthe pages 8-10, baasanjav2011faultyinitiationof pages 6-7)	HPO suggestions: Pectus excavatum/carinatum; Arachnodactyly; Hypotonia; Low bone mineral density; Strabismus; Refractive error	Heterogeneous and incompletely reported across studies.
Anatomy affected	Primary systems affected are skeletal/connective tissue and cardiovascular; secondary involvement can include craniofacial bones, eyes, and growth/endocrine features. (baasanjav2011faultyinitiationof pages 2-3, ritelli2019furtherdefiningthe pages 3-5, ritelli2019furtherdefiningthe pages 14-16)	UBERON suggestions: skeleton; joint; cartilage; heart valve; aorta; craniofacial skeleton	Organ mapping is inferred from clinical phenotypes and tissue expression rather than systematic pathology series.
Tissue / cell types / biological process	Relevant tissues/cells include cartilage/chondrocytes, osteoblast-lineage cells, fibroblasts, and aortic/valvular connective tissues. Mouse expression data showed B3gat3 in heart, aorta, bone, and osteoblasts. (baasanjav2011faultyinitiationof pages 6-7, holmborn2012ontheroles pages 1-2, holmborn2012ontheroles pages 8-9)	CL suggestions: chondrocyte; osteoblast; fibroblast. GO suggestions: extracellular matrix organization; cartilage development; skeletal system development; heart valve development; glycosaminoglycan biosynthesis	Cell-type evidence is partly indirect; human single-cell/spatial data were not found.
Onset / temporal development	Disease is typically congenital or neonatal/early childhood onset with structural anomalies apparent prenatally or at birth in severe cases and progressive orthopedic burden during childhood in survivors. (baasanjav2011faultyinitiationof pages 2-3, yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 3-5)	Onset term: congenital onset / neonatal onset	Natural history remains poorly defined because of few longitudinal cohorts.
Diagnostics	Diagnosis currently relies on phenotype recognition plus molecular testing (single-gene analysis, gene panels, trio exome sequencing, or broader genomic testing), with segregation confirmation. Cardiac imaging and skeletal radiography are important supportive assessments. (ritelli2019furtherdefiningthe pages 3-5, yauy2018b3gat3relateddisorderwith pages 6-6, baasanjav2011faultyinitiationof pages 3-4)	Diagnostic labels: exome sequencing; gene panel; Sanger confirmation; echocardiography; skeletal radiography	No consensus formal diagnostic criteria or validated standalone biochemical clinical test were identified.
Differential diagnosis	Differential diagnoses discussed in the literature include classic Larsen syndrome, CHST3-related autosomal recessive Larsen syndrome, Antley-Bixler syndrome, Shprintzen-Goldberg syndrome, geroderma osteodysplastica, spondylodysplastic EDS, musculocontractural EDS, Noonan syndrome, Desbuquois syndrome, and otopalatodigital syndrome type II. (yauy2018b3gat3relateddisorderwith pages 6-6, ritelli2019furtherdefiningthe pages 3-5, baasanjav2011faultyinitiationof pages 8-10)	Differential diagnosis labels as listed	Differential framing comes from case-report clinical reasoning, not guideline-based algorithms.
Management / real-world implementation	Management is supportive and multidisciplinary: orthopedic surveillance/intervention for dislocations, scoliosis, instability, and fractures; cardiology surveillance/intervention for structural heart disease; rehabilitation/physical therapy; pain management; ophthalmology follow-up; and genetic counseling. Reported real-world interventions include atrial septal defect repair, pulmonary hypertension management, and bisphosphonate treatment for low bone mineral density in an adolescent patient. (ritelli2019furtherdefiningthe pages 3-5)	NCIT suggestions: Physical Therapy; Orthopedic Procedure; Cardiac Surgical Procedure; Genetic Counseling; Bisphosphonate Therapy	Evidence is limited to case-based management; no standardized treatment algorithm specific to B3GAT3 disease.
Pharmacotherapy / advanced therapeutics	No disease-modifying pharmacotherapy, gene therapy, RNA therapy, or targeted molecular treatment specific to B3GAT3-related disease was found. (ritelli2019furtherdefiningthe pages 3-5, yauy2018b3gat3relateddisorderwith pages 6-6)	NCIT suggestions if supportive only: Bisphosphonate Therapy; Analgesic Therapy	Negative evidence based on available literature/trial search, not proof of absence of off-label use anywhere.
Prognosis	Prognosis is highly variable. Severe p.Gly223Ser cases showed infantile lethality, with reports that all described patients died before age 1 year; other individuals survive into adolescence/adulthood with chronic orthopedic and cardiac morbidity. (yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 10-12, ritelli2019furtherdefiningthe pages 3-5)	Prognosis labels: variable severity; infantile lethal subset	No survival curves or formal prognostic models exist.
Epidemiology / population	Ultra-rare disorder with no robust prevalence or incidence estimates identified. Reported families include multiple consanguineous pedigrees; one severe recurrent variant cohort involved families of Moroccan origin. (yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 10-12)	Epidemiology label: ultra-rare Mendelian disease	Published population data are case-based only; no registry-derived denominator.
Protective/environmental factors	No established environmental risk factors, protective factors, or gene-environment interactions specific to this Mendelian disorder were identified. (baasanjav2011faultyinitiationof pages 2-3, ritelli2019furtherdefiningthe pages 10-12)	Not established	Absence reflects evidence gap, not demonstrated nonexistence.
Clinical trials	Literature and trial search found no disease-specific interventional clinical trials for Larsen-like syndrome, B3GAT3 type. (OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3)	ClinicalTrials.gov / ICTRP status: none found	Search-negative result; trials could emerge later under broader linkeropathy terminology.
Other species / natural disease	No confirmed naturally occurring veterinary/nonhuman disease equivalent was identified from the retrieved evidence. (OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3)	Not established	Evidence gap; available literature focused on engineered models.
Model organisms	The clearest direct model is engineered zebrafish b3gat3 mutant (b3gat3hi307). Mutants showed near-abolished CS production with residual HS, undersulfated CS, and abnormal pharyngeal cartilage morphology/ECM, supporting a mechanism in cartilage morphogenesis. (holmborn2012ontheroles pages 1-2, holmborn2012ontheroles pages 8-9)	Model labels: zebrafish mutant; engineered loss-of-function model	Useful mechanistically but does not capture the full human multisystem/cardiac spectrum.
Model-mechanism insight	Zebrafish work suggests that when linker-region biosynthesis is impaired, HS biosynthesis is relatively prioritized over CS, and defective CS-rich cartilage ECM contributes to malformed cartilage. (holmborn2012ontheroles pages 1-2, holmborn2012ontheroles pages 8-9)	GO suggestions: cartilage morphogenesis; extracellular matrix assembly; heparan sulfate/chondroitin sulfate biosynthesis	Model inference; not directly measured in human tissues beyond fibroblast GAG assays.
Recent developments (2023-2024)	No major new disease-specific patient cohort or therapy was found in 2023-2024 from the retrieved search. The main recent advance is a 2024 pathway-level model emphasizing flux between HSPG/CSPG biosynthesis and how linkeropathy phenotypes may arise from preferential HSPG over CSPG production. (OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3)	Pathway label: HSPG/CSPG biosynthesis model	Recent literature is mainly review/conceptual rather than new clinical intervention evidence.

Table: This compact table summarizes the main evidence-backed knowledge-base facts for Larsen-like syndrome, B3GAT3 type, including identifiers, mechanism, phenotype spectrum, diagnosis, management, prognosis, and models. It also highlights key limitations: very small family-based cohorts, unstable frequency estimates, and the absence of disease-modifying therapy or disease-specific trials.

1. Disease information

Definition and identifiers

Preferred label: Larsen-like syndrome, B3GAT3 type.
Broader/current label: B3GAT3-related disorder or B3GAT3-related linkeropathy.
MONDO: MONDO:0009511.
OMIM phenotype: 245600 (historically Larsen syndrome/“Larsen-like syndrome, B3GAT3 type” in the cited literature).
Causal gene: B3GAT3, encoding beta-1,3-glucuronyltransferase 3 (GlcAT-I); Ensembl ENSG00000149541.
MeSH/Orphanet/ICD-10/ICD-11: no disease-specific identifier was established in the retrieved evidence. Coding will generally require a broader congenital skeletal dysplasia/connective-tissue category plus manifestations. A specific code should not be inferred without direct terminology-service verification. Open Targets supports the MONDO–B3GAT3 association with five evidence records and foundational PMIDs including 21763480, 24668659, 25893793, 26086840, 27604308, and 27871226. (OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3)

The defining report was Baasanjav et al., published 15 July 2011 in American Journal of Human Genetics (PMID 21763480; DOI/URL: https://doi.org/10.1016/j.ajhg.2011.05.021). Its central conclusion was that faulty proteoglycan synthesis causes cardiac and joint defects, and the authors proposed “Larsen-like syndrome, B3GAT3 type.” (baasanjav2011faultyinitiationof pages 2-3)

2. Etiology, risk, and protective factors

The disease is caused by germline biallelic B3GAT3 variants and is inherited autosomal recessively. The original pedigree carried homozygous NM_012200.3:c.830G>A, p.(Arg277Gln). The variant segregated with disease, affected a conserved substrate-binding residue, and was absent from 294 population-matched and 850 Berlin blood-donor chromosomes in the original study. (baasanjav2011faultyinitiationof pages 6-7, baasanjav2011faultyinitiationof pages 3-4)

Other reported alleles include c.419C>T (p.Pro140Leu), c.416C>T (p.Thr139Met), c.245C>T (p.Pro82Leu), c.667G>A (p.Gly223Ser), c.481C>T (p.Arg161Trp), c.889C>T (p.Arg297Trp), and compound-heterozygous c.1A>G (predicted start loss)/c.671T>A (p.Leu224Gln). Most reported disease alleles are missense and appear hypomorphic, although direct functional confirmation is not available for every allele. (ritelli2019furtherdefiningthe pages 8-10, ritelli2019furtherdefiningthe pages 10-12)

Consanguinity increases the probability that both parents carry the same rare allele but is not itself causal. The severe p.Gly223Ser series involved healthy first-cousin parents of Moroccan origin; the variant frequency was reported as approximately 8×10⁻⁶ in ExAC. No validated susceptibility loci, modifier genes, protective alleles, environmental risk or protective factors, infectious triggers, lifestyle effects, or gene–environment interactions have been demonstrated. (yauy2018b3gat3relateddisorderwith pages 2-4)

3. Phenotypes

Musculoskeletal and growth manifestations

The core phenotype begins congenitally or in early childhood and includes short stature, generalized or distal joint hypermobility, multiple dislocations (shoulder, elbow, hip, knee, and proximal radioulnar joints), elbow contractures, radioulnar synostosis, kyphosis/scoliosis, foot deformities, metaphyseal abnormalities, delayed bone age, osteopenia, and variably fractures. Orthopedic burden can progress with growth even though the initiating developmental defect is congenital. Suggested HPO terms include Short stature; Joint hypermobility; Joint dislocation; Congenital hip dislocation; Radioulnar synostosis; Joint contracture; Scoliosis; Kyphosis; Osteopenia; Low bone mineral density; Multiple fractures; Talipes equinovarus; Hallux valgus; and Pes planus. (baasanjav2011faultyinitiationof pages 2-3, ritelli2019furtherdefiningthe pages 3-5, ritelli2019furtherdefiningthe pages 8-10, baasanjav2011faultyinitiationof pages 6-7)

In the p.Gly223Ser severe subgroup, reported frequencies included radioulnar synostosis 6/6 postnatal patients, contractures 100%, foot deformity 100%, neonatal fractures 67%, long fingers 67%, and joint dislocation approximately 60%. These numbers must not be generalized to all B3GAT3 genotypes. (yauy2018b3gat3relateddisorderwith pages 2-4)

Craniofacial, ocular, and cutaneous manifestations

Reported findings include midface hypoplasia, depressed nasal bridge, frontal bossing or broad forehead, hypertelorism or prominent eyes, downslanting palpebral fissures, micrognathia, small mouth, long philtrum, low-set ears, short/webbed neck, blue sclerae, refractive error, strabismus, and occasionally cleft palate or bifid uvula. Craniosynostosis is especially associated with severe presentations. Suggested HPO terms include Midface retrusion; Depressed nasal bridge; Frontal bossing; Hypertelorism; Proptosis; Downslanting palpebral fissures; Micrognathia; Blue sclerae; Craniosynostosis; Strabismus; Refractive error; Webbed neck; Cleft palate; and Bifid uvula. (yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 14-16, ritelli2019furtherdefiningthe pages 8-10, baasanjav2011faultyinitiationof pages 3-4)

Cardiovascular manifestations

Congenital cardiovascular disease is an important clue and includes bicuspid aortic valve, aortic-valve dysplasia, mitral-valve prolapse, atrial or ventricular septal defects, pulmonary hypertension, and aortic-root dilatation. Suggested HPO terms are Bicuspid aortic valve; Mitral valve prolapse; Atrial septal defect; Ventricular septal defect; Pulmonary hypertension; and Aortic root dilatation. Cardiovascular disease is enriched in B3GAT3 linkeropathy relative to several related linkeropathies but is not universal. (baasanjav2011faultyinitiationof pages 2-3, ritelli2019furtherdefiningthe pages 3-5, ritelli2019furtherdefiningthe pages 14-16)

Neurologic, developmental, and quality-of-life effects

Neonatal hypotonia and delayed gross-motor development can occur, often plausibly secondary to skeletal disease and instability. The reported Italian girl walked at age three and had chronic myalgia and severe foot pain; by contrast, the original family had normal mental and motor development. Developmental delay is therefore variable, and a primary behavioral phenotype is not established. Chronic pain, impaired mobility, recurrent dislocations, spinal deformity, fractures, surgery, and cardiac disease are expected to impair daily function, but no disease-specific EQ-5D, SF-36, PROMIS, or other quantitative quality-of-life study was found. Suggested HPO terms include Hypotonia; Delayed gross motor development; Musculoskeletal pain; and Abnormality of cardiovascular system. (ritelli2019furtherdefiningthe pages 3-5, baasanjav2011faultyinitiationof pages 6-7)

4. Genetic and molecular information

B3GAT3/GlcAT-I transfers the fourth sugar, glucuronic acid, to the common Xyl–Gal–Gal–GlcA linker through which chondroitin sulfate (CS), dermatan sulfate (DS), and heparan sulfate (HS) chains attach to proteoglycan core proteins. GlcAT-I functions in the Golgi and forms a dimer; Arg277 is positioned in the acceptor/substrate-interaction domain. (mizumoto2018defectsinbiosynthesis pages 9-10, baasanjav2011faultyinitiationof pages 6-7, baasanjav2011faultyinitiationof pages 3-4)

For p.Arg277Gln, patient fibroblasts had only 3–5% of control GlcAT-I activity. The mutant protein showed reduced abundance and loss of normal cis/cis-medial-Golgi localization, while recombinant mutant enzyme retained similarly reduced catalytic activity despite comparable protein loading. The allele is therefore a hypomorphic loss-of-function allele involving both catalytic dysfunction and reduced protein stability/localization. Cell-surface CS and HS were approximately 65% and 53% of control, respectively, and immature DS proteoglycans were detected. (baasanjav2011faultyinitiationof pages 8-10, baasanjav2011faultyinitiationof pages 6-7)

All known disease variants are germline; no somatic disease mechanism is recognized. No established modifier gene, disease-specific methylation signature, chromosomal rearrangement, repeat expansion, mitochondrial defect, or large structural abnormality was identified. ACMG classification should be performed separately for each variant using segregation, population frequency, computational evidence, functional data, and current ClinVar submissions; the literature’s “likely pathogenic” designation should not automatically be transferred to every laboratory context. Functional effects of p.Arg161Trp and p.Arg297Trp, for example, were not tested in patient fibroblasts. (ritelli2019furtherdefiningthe pages 3-5, ritelli2019furtherdefiningthe pages 8-10)

5. Environmental information

No toxin, radiation, pollution, occupational exposure, diet, smoking, alcohol, exercise pattern, or infectious agent is known to cause or trigger this disorder. It is a congenital Mendelian condition. Environmental and rehabilitative factors may alter complication burden and function, but they have not been studied as etiologic or protective factors. Vaccination and infection-control measures follow routine standards rather than a B3GAT3-specific protocol.

6. Mechanism and pathophysiology

The best-supported causal chain is:

biallelic B3GAT3 dysfunction → reduced/mislocalized Golgi GlcAT-I → incomplete proteoglycan linker tetrasaccharides → reduced or abnormal CS/DS/HS chains → impaired extracellular-matrix assembly and altered presentation of morphogens/growth factors → defective cartilage morphogenesis, endochondral ossification, connective-tissue mechanics, and cardiac-valve/aortic development → dislocations, contractures, short stature, bone fragility, craniofacial abnormalities, and cardiovascular malformations. (baasanjav2011faultyinitiationof pages 2-3, baasanjav2011faultyinitiationof pages 8-10, baasanjav2011faultyinitiationof pages 6-7, holmborn2012ontheroles pages 1-2)

The upstream lesion is linker synthesis; downstream effects include extracellular-matrix insufficiency and disturbed signaling. Proteoglycans act as structural molecules and co-receptors for BMP, Hedgehog, Wnt, and FGF-family signals, although a specific signaling pathway has not been proven to account for every human manifestation. Relevant suggested GO terms are glycosaminoglycan biosynthetic process; proteoglycan biosynthetic process; extracellular matrix organization; cartilage development; endochondral ossification; skeletal system development; heart valve development; and Golgi apparatus organization. Relevant cellular compartments are Golgi apparatus, cis-Golgi/cis-medial Golgi, cell surface, and extracellular matrix. (baasanjav2011faultyinitiationof pages 6-7, holmborn2012ontheroles pages 1-2)

Candidate cell types are chondrocyte (CL term label), osteoblast, fibroblast, valvular interstitial cell, vascular smooth-muscle cell, and related mesenchymal progenitors. Direct human single-cell, spatial-transcriptomic, proteomic, metabolomic, lipidomic, epigenomic, organoid, iPSC, or CRISPR-screen datasets specific to this disease were not found. Mouse tissue assays showed B3gat3 expression in heart, aorta, bone, and osteoblast cultures, but this is supportive expression evidence rather than a complete disease atlas. (baasanjav2011faultyinitiationof pages 6-7)

A 2024 pathway review proposed that substrate preference and pathway flux can privilege HSPG over CSPG synthesis when the common linker pathway is constrained. This is consistent with zebrafish b3gat3 mutants retaining substantial HS while nearly abolishing CS, but it remains a pathway-level model rather than a tested human therapy. Publication: Ouidja et al., December 2024, DOI https://doi.org/10.1042/EBC20240106. (OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3, holmborn2012ontheroles pages 1-2, holmborn2012ontheroles pages 8-9)

7. Anatomical structures affected

Primary sites are cartilage, bone, joints, spine, craniofacial skeleton, tendons/ligaments and other connective tissues, heart valves, septa, and aortic root. Suggested UBERON labels include cartilage; bone tissue; joint; vertebral column; craniofacial skeleton; heart valve; interatrial septum; aortic root; tendon; and ligament. Disease can be bilateral and generalized; radioulnar synostosis and limb/joint abnormalities are commonly bilateral, but strict lateralization is not universal. At the subcellular level, the Golgi is the principal biosynthetic compartment and the extracellular matrix is the major downstream affected compartment. (baasanjav2011faultyinitiationof pages 2-3, ritelli2019furtherdefiningthe pages 14-16, baasanjav2011faultyinitiationof pages 6-7)

8. Temporal development

Onset is congenital, prenatal, neonatal, or early childhood. Severe disease can be detected prenatally through fractures, craniosynostosis, limb abnormalities, or other skeletal findings. Survivors have a chronic lifelong disorder: congenital dislocations and malformations may be relatively fixed, whereas scoliosis, pain, instability, osteopenia, mobility restriction, and cardiovascular complications may progress. There is no recognized relapsing-remitting course or spontaneous molecular remission. Early vulnerability corresponds to embryonic cartilage, bone, craniofacial, and cardiovascular development; practical intervention windows concern early recognition of cervical instability, cardiac disease, dislocations, and bone fragility rather than reversal of the biochemical defect. (yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 3-5, baasanjav2011faultyinitiationof pages 6-7)

9. Inheritance and population

Inheritance is autosomal recessive. For a couple in whom both partners carry the same pathogenic B3GAT3 allele, each pregnancy has the conventional 25% affected, 50% carrier, and 25% non-carrier probability. Expressivity is markedly variable across alleles; formal penetrance, carrier frequency, sex ratio, incidence, and prevalence have not been quantified. No anticipation mechanism is expected, and germline mosaicism has not been established. (yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 10-12)

The disease is ultra-rare and reported across multiple ancestries. Moroccan families recur in the p.Gly223Ser series, but the data are insufficient to prove a population founder effect. Consanguinity was present in most early families and facilitates homozygosity for rare alleles. There is no evidence of sex-limited expression. (yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 10-12)

10. Diagnostics

Clinical and imaging evaluation

Suspect B3GAT3-related disease when congenital joint dislocations or contractures coexist with short stature/skeletal dysplasia, radioulnar synostosis, characteristic craniofacial findings, osteopenia/fractures, and congenital cardiac disease. Baseline assessment should include a skeletal survey or targeted radiographs; spine and cervical-instability imaging when indicated; echocardiography with aortic-root measurements; ophthalmologic examination; growth and developmental assessment; and bone-density evaluation in appropriate children or adults. These evaluations characterize manifestations but are not individually diagnostic. (ritelli2019furtherdefiningthe pages 3-5, ritelli2019furtherdefiningthe pages 8-10, baasanjav2011faultyinitiationof pages 3-4)

GlcAT-I activity and cellular GAG analysis are research-supportive biomarkers, not validated routine diagnostic thresholds. Routine blood and urine chemistry may be nonspecific. Biopsy is not ordinarily required. (baasanjav2011faultyinitiationof pages 8-10, baasanjav2011faultyinitiationof pages 6-7)

Genetic testing

A practical sequence is: (1) a skeletal-dysplasia/connective-tissue disorder panel containing B3GAT3, B4GALT7, B3GALT6, XYLT1, XYLT2, CHST3, CHST14, DSE, FLNB, POR, FGFR2, CYP26B1, and phenotype-relevant genes; or (2) trio WES/WGS where the phenotype is atypical; followed by orthogonal confirmation and parental segregation. WES identified the severe p.Gly223Ser disorder, while panel and Sanger testing confirmed additional patients. Copy-number analysis should be included when sequencing is negative. CMA/karyotype may be appropriate for a syndromic child but will not detect most reported B3GAT3 missense alleles. FISH, mitochondrial sequencing, and repeat-expansion testing are not disease-specific tests. (yauy2018b3gat3relateddisorderwith pages 2-4, yauy2018b3gat3relateddisorderwith pages 6-6, ritelli2019furtherdefiningthe pages 3-5)

Differential diagnoses include FLNB-related classic Larsen syndrome, CHST3-related recessive Larsen phenotype, B4GALT7/B3GALT6 spondylodysplastic EDS, XYLT1/XYLT2 linkeropathies, Desbuquois dysplasia, musculocontractural EDS, Antley-Bixler syndrome, Shprintzen-Goldberg syndrome, geroderma osteodysplastica, Noonan syndrome, and otopalatodigital syndrome type II. In prenatal or craniosynostosis/bone-fragility presentations, B3GAT3 should be considered alongside POR, FGFR2, and CYP26B1. (yauy2018b3gat3relateddisorderwith pages 6-6, baasanjav2011faultyinitiationof pages 8-10)

No validated population newborn screen exists. Cascade testing of relatives and targeted carrier, prenatal, or preimplantation testing are possible once familial pathogenic variants are known.

11. Outcome and prognosis

Prognosis is allele- and severity-dependent. In the reported p.Gly223Ser cohort, all described patients died before one year, indicating a severe infantile-lethal subgroup; reported complications included neonatal fractures, craniosynostosis, contractures, and cardiovascular abnormalities. Other genotypes permit survival into adolescence and adulthood, but with chronic orthopedic disability, pain, spinal disease, low bone density, recurrent operations, and cardiac surveillance needs. (yauy2018b3gat3relateddisorderwith pages 2-4, ritelli2019furtherdefiningthe pages 3-5)

No population survival curve, five- or ten-year survival statistic, mortality rate, validated prognostic score, or prognostic biomarker exists. Potential adverse indicators inferred from cases include severe neonatal fractures, respiratory/diaphragmatic involvement, major congenital heart disease, pulmonary hypertension, craniosynostosis, and cervical instability. Recovery from the underlying disorder is not expected, although correction of individual dislocations, deformities, instability, or cardiac lesions may improve function and risk.

12. Treatment and current implementation

There is no approved disease-modifying treatment and no disease-specific interventional trial was identified. Care is multidisciplinary and manifestation-directed:

Orthopedics/spine: surveillance and individualized reduction, stabilization, casting/bracing, or reconstructive surgery for dislocations, contractures, scoliosis, foot deformity, and cervical instability.
Cardiology/cardiothoracic care: serial echocardiography and intervention for septal defects, valve disease, aortic dilatation, or pulmonary hypertension. An affected adolescent underwent atrial-septal-defect repair.
Bone health: nutrition, vitamin D/calcium sufficiency, fall/fracture prevention, and specialist-guided antiresorptive treatment. Bisphosphonate therapy was used in one patient with low bone mineral density, but no response rate or B3GAT3-specific efficacy estimate exists.
Rehabilitation: cautious physical and occupational therapy, mobility aids, pain management, and avoidance of maneuvers that provoke dislocation or threaten an unstable cervical spine.
Ophthalmology, growth/endocrinology, respiratory care, and developmental services according to manifestations.
Genetic counseling for recurrence risk and reproductive options. (ritelli2019furtherdefiningthe pages 3-5)

Suggested NCIT intervention labels include Genetic Counseling, Physical Therapy, Occupational Therapy, Orthopedic Surgical Procedure, Cardiac Surgical Procedure, Echocardiography, and Bisphosphonate Therapy. No B3GAT3-specific pharmacogenomic recommendation, gene replacement, genome editing, antisense, siRNA, mRNA, cell therapy, immunotherapy, or targeted small molecule has entered established clinical use.

13. Prevention

Primary prevention by lifestyle or vaccination is not applicable to occurrence of this recessive genetic disorder. Reproductive prevention options are voluntary carrier/cascade testing, genetic counseling, prenatal diagnosis, and preimplantation genetic testing after familial variants are established. Secondary prevention consists of early molecular diagnosis and surveillance for cardiac disease, cervical instability, progressive scoliosis, dislocation, hearing/vision issues, low bone density, and fracture. Tertiary prevention includes rehabilitation, injury avoidance, bone-health measures, timely orthopedic/cardiac intervention, and peri-anesthetic attention to airway and cervical-spine abnormalities. No public-health environmental intervention or chemoprophylaxis is specific to B3GAT3 disease.

14. Other species and natural disease

No verified naturally occurring B3GAT3-equivalent veterinary disease, breed association, zoonotic transmission, or cross-species infectious susceptibility was found. The condition is noninfectious and has no zoonotic potential. Comparative evidence comes from engineered laboratory models rather than natural animal cases.

15. Model organisms

The most direct model is the engineered b3gat3hi307 zebrafish (Danio rerio; NCBI Taxonomy 7955). Mutants have reduced common-linker availability, near-abolition of CS biosynthesis, retention of roughly half-normal HS production, altered CS sulfation, and abnormal pharyngeal-cartilage morphology. The study concluded that “HS biosynthesis is prioritized over CS biosynthesis” under linker limitation; impaired CS particularly disrupted extracellular matrix around chondrocytes, whereas HS defects more strongly affected chondrocyte intercalation. Publication: Holmborn et al., 28 September 2012, Journal of Biological Chemistry, DOI https://doi.org/10.1074/jbc.M112.401646. (holmborn2012ontheroles pages 1-2, holmborn2012ontheroles pages 8-9)

This model is useful for cartilage morphogenesis, GAG flux, extracellular-matrix biology, and candidate-rescue studies. Limitations include developmental-stage and species differences and incomplete reproduction of human valve, aortic, neurologic, and long-term orthopedic disease. Retrieved mouse evidence primarily documented B3gat3 tissue expression rather than a fully characterized disease-equivalent model; claims about a definitive mouse phenocopy should therefore be avoided. (baasanjav2011faultyinitiationof pages 6-7)

Research outlook and expert analysis

The principal expert consensus is that B3GAT3 disease belongs to a continuum bridging skeletal dysplasia and Ehlers-Danlos–like connective-tissue disease, rather than several completely separate syndromes. The strongest research priorities are international natural-history aggregation, standardized variant curation, longitudinal cardiac and skeletal outcomes, validated GAG biomarkers, allele-specific functional assays, and human chondrocyte/valvular iPSC models. The 2023–2024 search found no major new disease-specific patient cohort or therapeutic study; recent progress is predominantly conceptual glycobiology rather than clinical translation. (ritelli2019furtherdefiningthe pages 10-12, ritelli2019furtherdefiningthe pages 1-3, OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3)

Key primary and review sources

Baasanjav S, et al. “Faulty initiation of proteoglycan synthesis causes cardiac and joint defects.” Am J Hum Genet. 15 July 2011;89:15–27. PMID: 21763480. https://doi.org/10.1016/j.ajhg.2011.05.021. Direct human pedigree, biochemical, cellular, and recombinant-enzyme evidence. (baasanjav2011faultyinitiationof pages 2-3, baasanjav2011faultyinitiationof pages 6-7)
Yauy K, et al. “B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation.” Genet Med. February 2018;20:269–274. https://doi.org/10.1038/gim.2017.109. Direct severe-phenotype human series. (yauy2018b3gat3relateddisorderwith pages 2-4, yauy2018b3gat3relateddisorderwith pages 6-6)
Ritelli M, et al. “Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes.” Genes. August 2019;10:631. https://doi.org/10.3390/genes10090631. New human case plus aggregated review. (ritelli2019furtherdefiningthe pages 10-12, ritelli2019furtherdefiningthe pages 3-5)
Holmborn K, et al. “On the Roles and Regulation of Chondroitin Sulfate and Heparan Sulfate in Zebrafish Pharyngeal Cartilage Morphogenesis.” J Biol Chem. 28 September 2012;287:33905–33916. https://doi.org/10.1074/jbc.M112.401646. Engineered zebrafish evidence. (holmborn2012ontheroles pages 1-2, holmborn2012ontheroles pages 8-9)

Quoted abstract language should be interpreted in context. The 2019 review states: “The term linkeropathies (LKs) refers to a group of rare heritable connective tissue disorders,” and concludes that they form “a phenotypic continuum bridging EDS and skeletal disorders.” The zebrafish study’s abstract-level conclusion is that “HS biosynthesis is prioritized over CS biosynthesis.” These statements summarize review/model interpretations and do not substitute for patient-level outcome data. (ritelli2019furtherdefiningthe pages 1-3, holmborn2012ontheroles pages 1-2)

References

(baasanjav2011faultyinitiationof pages 2-3): Sevjidmaa Baasanjav, Lihadh Al-Gazali, Taishi Hashiguchi, Shuji Mizumoto, Bjoern Fischer, Denise Horn, Dominik Seelow, Bassam R. Ali, Samir A.A. Aziz, Ruth Langer, Ahmed A.H. Saleh, Christian Becker, Gudrun Nürnberg, Vincent Cantagrel, Joseph G. Gleeson, Delphine Gomez, Jean-Baptiste Michel, Sigmar Stricker, Tom H. Lindner, Peter Nürnberg, Kazuyuki Sugahara, Stefan Mundlos, and Katrin Hoffmann. Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. American journal of human genetics, 89 1:15-27, Jul 2011. URL: https://doi.org/10.1016/j.ajhg.2011.05.021, doi:10.1016/j.ajhg.2011.05.021. This article has 152 citations and is from a highest quality peer-reviewed journal.
(yauy2018b3gat3relateddisorderwith pages 2-4): Kevin Yauy, Frederic Tran Mau-Them, Marjolaine Willems, Christine Coubes, Patricia Blanchet, Christian Herlin, Ikram Taleb Arrada, Elodie Sanchez, Jean-Michel Faure, Marie-Pascale Le Gac, Olivier Prodhomme, Anne Boland, Vincent Meyer, Jean-Baptiste Rivière, Yannis Duffourd, Jean-François Deleuze, Thomas Guignard, Guillaume Captier, Mouna Barat-Houari, and David Genevieve. B3gat3-related disorder with craniosynostosis and bone fragility due to a unique mutation. Genetics in Medicine, 20:269-274, Feb 2018. URL: https://doi.org/10.1038/gim.2017.109, doi:10.1038/gim.2017.109. This article has 35 citations and is from a highest quality peer-reviewed journal.
(ritelli2019furtherdefiningthe pages 10-12): Marco Ritelli, Valeria Cinquina, Edoardo Giacopuzzi, Marina Venturini, Nicola Chiarelli, and Marina Colombi. Further defining the phenotypic spectrum of b3gat3 mutations and literature review on linkeropathy syndromes. Genes, 10:631, Aug 2019. URL: https://doi.org/10.3390/genes10090631, doi:10.3390/genes10090631. This article has 47 citations.
(OpenTargets Search: Larsen-like syndrome B3GAT3 type-B3GAT3): Open Targets Query (Larsen-like syndrome B3GAT3 type-B3GAT3, 2 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(ritelli2019furtherdefiningthe pages 1-3): Marco Ritelli, Valeria Cinquina, Edoardo Giacopuzzi, Marina Venturini, Nicola Chiarelli, and Marina Colombi. Further defining the phenotypic spectrum of b3gat3 mutations and literature review on linkeropathy syndromes. Genes, 10:631, Aug 2019. URL: https://doi.org/10.3390/genes10090631, doi:10.3390/genes10090631. This article has 47 citations.
(mizumoto2018defectsinbiosynthesis pages 9-10): Shuji Mizumoto. Defects in biosynthesis of glycosaminoglycans cause hereditary bone, skin, heart, immune, and neurological disorders. Trends in Glycoscience and Glycotechnology, 30:E67-E89, May 2018. URL: https://doi.org/10.4052/tigg.1812.2e, doi:10.4052/tigg.1812.2e. This article has 14 citations and is from a peer-reviewed journal.
(ritelli2019furtherdefiningthe pages 8-10): Marco Ritelli, Valeria Cinquina, Edoardo Giacopuzzi, Marina Venturini, Nicola Chiarelli, and Marina Colombi. Further defining the phenotypic spectrum of b3gat3 mutations and literature review on linkeropathy syndromes. Genes, 10:631, Aug 2019. URL: https://doi.org/10.3390/genes10090631, doi:10.3390/genes10090631. This article has 47 citations.
(baasanjav2011faultyinitiationof pages 8-10): Sevjidmaa Baasanjav, Lihadh Al-Gazali, Taishi Hashiguchi, Shuji Mizumoto, Bjoern Fischer, Denise Horn, Dominik Seelow, Bassam R. Ali, Samir A.A. Aziz, Ruth Langer, Ahmed A.H. Saleh, Christian Becker, Gudrun Nürnberg, Vincent Cantagrel, Joseph G. Gleeson, Delphine Gomez, Jean-Baptiste Michel, Sigmar Stricker, Tom H. Lindner, Peter Nürnberg, Kazuyuki Sugahara, Stefan Mundlos, and Katrin Hoffmann. Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. American journal of human genetics, 89 1:15-27, Jul 2011. URL: https://doi.org/10.1016/j.ajhg.2011.05.021, doi:10.1016/j.ajhg.2011.05.021. This article has 152 citations and is from a highest quality peer-reviewed journal.
(baasanjav2011faultyinitiationof pages 6-7): Sevjidmaa Baasanjav, Lihadh Al-Gazali, Taishi Hashiguchi, Shuji Mizumoto, Bjoern Fischer, Denise Horn, Dominik Seelow, Bassam R. Ali, Samir A.A. Aziz, Ruth Langer, Ahmed A.H. Saleh, Christian Becker, Gudrun Nürnberg, Vincent Cantagrel, Joseph G. Gleeson, Delphine Gomez, Jean-Baptiste Michel, Sigmar Stricker, Tom H. Lindner, Peter Nürnberg, Kazuyuki Sugahara, Stefan Mundlos, and Katrin Hoffmann. Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. American journal of human genetics, 89 1:15-27, Jul 2011. URL: https://doi.org/10.1016/j.ajhg.2011.05.021, doi:10.1016/j.ajhg.2011.05.021. This article has 152 citations and is from a highest quality peer-reviewed journal.
(ritelli2019furtherdefiningthe pages 14-16): Marco Ritelli, Valeria Cinquina, Edoardo Giacopuzzi, Marina Venturini, Nicola Chiarelli, and Marina Colombi. Further defining the phenotypic spectrum of b3gat3 mutations and literature review on linkeropathy syndromes. Genes, 10:631, Aug 2019. URL: https://doi.org/10.3390/genes10090631, doi:10.3390/genes10090631. This article has 47 citations.
(ritelli2019furtherdefiningthe pages 3-5): Marco Ritelli, Valeria Cinquina, Edoardo Giacopuzzi, Marina Venturini, Nicola Chiarelli, and Marina Colombi. Further defining the phenotypic spectrum of b3gat3 mutations and literature review on linkeropathy syndromes. Genes, 10:631, Aug 2019. URL: https://doi.org/10.3390/genes10090631, doi:10.3390/genes10090631. This article has 47 citations.
(holmborn2012ontheroles pages 1-2): Katarina Holmborn, Judith Habicher, Zsolt Kasza, Anna S. Eriksson, Beata Filipek-Gorniok, Sandeep Gopal, John R. Couchman, Per E. Ahlberg, Malgorzata Wiweger, Dorothe Spillmann, Johan Kreuger, and Johan Ledin. On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis. Journal of Biological Chemistry, 287:33905-33916, Sep 2012. URL: https://doi.org/10.1074/jbc.m112.401646, doi:10.1074/jbc.m112.401646. This article has 71 citations and is from a domain leading peer-reviewed journal.
(holmborn2012ontheroles pages 8-9): Katarina Holmborn, Judith Habicher, Zsolt Kasza, Anna S. Eriksson, Beata Filipek-Gorniok, Sandeep Gopal, John R. Couchman, Per E. Ahlberg, Malgorzata Wiweger, Dorothe Spillmann, Johan Kreuger, and Johan Ledin. On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis. Journal of Biological Chemistry, 287:33905-33916, Sep 2012. URL: https://doi.org/10.1074/jbc.m112.401646, doi:10.1074/jbc.m112.401646. This article has 71 citations and is from a domain leading peer-reviewed journal.
(yauy2018b3gat3relateddisorderwith pages 6-6): Kevin Yauy, Frederic Tran Mau-Them, Marjolaine Willems, Christine Coubes, Patricia Blanchet, Christian Herlin, Ikram Taleb Arrada, Elodie Sanchez, Jean-Michel Faure, Marie-Pascale Le Gac, Olivier Prodhomme, Anne Boland, Vincent Meyer, Jean-Baptiste Rivière, Yannis Duffourd, Jean-François Deleuze, Thomas Guignard, Guillaume Captier, Mouna Barat-Houari, and David Genevieve. B3gat3-related disorder with craniosynostosis and bone fragility due to a unique mutation. Genetics in Medicine, 20:269-274, Feb 2018. URL: https://doi.org/10.1038/gim.2017.109, doi:10.1038/gim.2017.109. This article has 35 citations and is from a highest quality peer-reviewed journal.
(baasanjav2011faultyinitiationof pages 3-4): Sevjidmaa Baasanjav, Lihadh Al-Gazali, Taishi Hashiguchi, Shuji Mizumoto, Bjoern Fischer, Denise Horn, Dominik Seelow, Bassam R. Ali, Samir A.A. Aziz, Ruth Langer, Ahmed A.H. Saleh, Christian Becker, Gudrun Nürnberg, Vincent Cantagrel, Joseph G. Gleeson, Delphine Gomez, Jean-Baptiste Michel, Sigmar Stricker, Tom H. Lindner, Peter Nürnberg, Kazuyuki Sugahara, Stefan Mundlos, and Katrin Hoffmann. Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. American journal of human genetics, 89 1:15-27, Jul 2011. URL: https://doi.org/10.1016/j.ajhg.2011.05.021, doi:10.1016/j.ajhg.2011.05.021. This article has 152 citations and is from a highest quality peer-reviewed journal.

Artifacts

Edison artifact artifact-00

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Progression

Prevalence

Differential Diagnoses

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Disease Characteristics Research Template

Target Disease

Research Objectives

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Citation Requirements

Output Format

Larsen-like syndrome, B3GAT3 type: comprehensive disease-characteristics report

Executive summary and evidence limits

1. Disease information

Definition and identifiers

2. Etiology, risk, and protective factors

3. Phenotypes

Musculoskeletal and growth manifestations

Craniofacial, ocular, and cutaneous manifestations

Cardiovascular manifestations

Neurologic, developmental, and quality-of-life effects

4. Genetic and molecular information

5. Environmental information

6. Mechanism and pathophysiology

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

10. Diagnostics

Clinical and imaging evaluation

Genetic testing

11. Outcome and prognosis

12. Treatment and current implementation

13. Prevention

14. Other species and natural disease

15. Model organisms

Research outlook and expert analysis

Key primary and review sources

Artifacts